Prescription and Over-the-Counter Drug Product List 41ST EDITION Cumulative Supplement Number 02 : February 2021 ADDITIONS/DELETIONS FOR PRODUCT LIST

ACETAMINOPHEN SOLUTION;INTRAVENOUS ACETAMINOPHEN >A> +! B BRAUN MEDICAL INC 500MG/50ML (10MG/ML) N 204957 001 Feb 18, 2021 Feb NEWA >A> +! 1GM/100ML (10MG/ML) N 204957 002 Feb 18, 2021 Feb NEWA

ACETAMINOPHEN; BUTALBITAL; CAFFEINE CAPSULE;ORAL BUTALBITAL, ACETAMINOPHEN AND CAFFEINE >D> AA WRASER PHARMS LLC 300MG;50MG;40MG A 206615 001 Aug 04, 2017 Feb CAHN >A> AA XSPIRE PHARMA 300MG;50MG;40MG A 206615 001 Aug 04, 2017 Feb CAHN

ACETAZOLAMIDE TABLET;ORAL ACETAZOLAMIDE >A> AB APPCO 125MG A 211372 001 Feb 22, 2021 Feb NEWA >A> AB 250MG A 211372 002 Feb 22, 2021 Feb NEWA

ACLIDINIUM BROMIDE POWDER, METERED;INHALATION TUDORZA PRESSAIR >A> +! ASTRAZENECA 0.4MG/INH N 202450 001 Jul 23, 2012 Feb CAHN >D> +! CIRCASSIA 0.4MG/INH N 202450 001 Jul 23, 2012 Feb CAHN

ACLIDINIUM BROMIDE; FUMARATE POWDER, METERED;INHALATION DUAKLIR PRESSAIR >A> ASTRAZENECA 0.4MG/INH;0.012MG/INH N 210595 001 Mar 29, 2019 Feb CAHN >D> CIRCASSIA 0.4MG/INH;0.012MG/INH N 210595 001 Mar 29, 2019 Feb CAHN

ADAPALENE; BENZOYL PEROXIDE GEL;TOPICAL EPIDUO FORTE >D> AB +! GALDERMA LABS 0.3%;2.5% N 207917 001 Jul 15, 2015 Feb CTEC >A> +! 0.3%;2.5% N 207917 001 Jul 15, 2015 Feb CTEC

ADENOSINE SOLUTION;INTRAVENOUS ADENOSINE >D> @ EMCURE PHARMS LTD 60MG/20ML (3MG/ML) A 202313 001 Sep 15, 2014 Feb CMFD >A> AP 60MG/20ML (3MG/ML) A 202313 001 Sep 15, 2014 Feb CMFD >D> @ 90MG/30ML (3MG/ML) A 202313 002 Sep 15, 2014 Feb CMFD >A> AP 90MG/30ML (3MG/ML) A 202313 002 Sep 15, 2014 Feb CMFD

ALBUTEROL SULFATE TABLET;ORAL ALBUTEROL SULFATE >D> @ AIZANT EQ 2MG BASE A 210948 001 Mar 15, 2019 Feb CMFD >A> AB EQ 2MG BASE A 210948 001 Mar 15, 2019 Feb CMFD >D> @ EQ 4MG BASE A 210948 002 Mar 15, 2019 Feb CMFD >A> AB EQ 4MG BASE A 210948 002 Mar 15, 2019 Feb CMFD

AMINOCAPROIC ACID SOLUTION;ORAL AMICAR >A> AA +! AKORN 0.25GM/ML N 015230 002 Oct 26, 1970 Feb CPOT AMINOCAPROIC ACID >A> AA AMNEAL 0.25GM/ML A 212780 001 Aug 23, 2019 Feb CPOT >A> AA LEADING PHARMA LLC 0.25GM/ML A 214140 001 Jan 26, 2021 Feb CPOT >A> AA TULEX PHARMS INC 0.25GM/ML A 212494 001 Aug 11, 2020 Feb CPOT >A> AA VISTAPHARM 0.25GM/ML A 212814 001 Feb 26, 2020 Feb CPOT SYRUP;ORAL AMICAR >D> AA +! AKORN 1.25GM/5ML N 015230 002 Oct 26, 1970 Feb CPOT AMINOCAPROIC ACID >D> AA AMNEAL 1.25GM/5ML A 212780 001 Aug 23, 2019 Feb CPOT

Page 1 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

AMINOCAPROIC ACID SYRUP;ORAL AMINOCAPROIC ACID >D> AA LEADING PHARMA LLC 1.25GM/5ML A 214140 001 Jan 26, 2021 Feb CPOT >D> AA TULEX PHARMS INC 1.25GM/5ML A 212494 001 Aug 11, 2020 Feb CPOT >D> AA VISTAPHARM 1.25GM/5ML A 212814 001 Feb 26, 2020 Feb CPOT TABLET;ORAL AMINOCAPROIC ACID >A> AB LEADING PHARMA LLC 500MG A 213928 001 Feb 12, 2021 Feb NEWA >A> AB 1GM A 213928 002 Feb 12, 2021 Feb NEWA

AMIODARONE HYDROCHLORIDE TABLET;ORAL AMIODARONE HYDROCHLORIDE >A> AB RUBICON 100MG A 078578 002 Feb 26, 2021 Feb NEWA >A> AB 400MG A 078578 003 Feb 26, 2021 Feb NEWA

AMITRIPTYLINE HYDROCHLORIDE TABLET;ORAL HYDROCHLORIDE >A> AB MANKIND PHARMA 10MG A 213999 001 Feb 19, 2021 Feb NEWA >A> AB 25MG A 213999 002 Feb 19, 2021 Feb NEWA >A> AB 50MG A 213999 003 Feb 19, 2021 Feb NEWA >A> AB 75MG A 213999 004 Feb 19, 2021 Feb NEWA >A> AB 100MG A 213999 005 Feb 19, 2021 Feb NEWA >A> AB 150MG A 213999 006 Feb 19, 2021 Feb NEWA

APREMILAST TABLET;ORAL >A> APREMILAST >A> AB UNICHEM 10MG A 211819 001 Feb 17, 2021 Feb NFTG >A> AB 20MG A 211819 002 Feb 17, 2021 Feb NFTG >A> AB 30MG A 211819 003 Feb 17, 2021 Feb NFTG

ARSENIC TRIOXIDE INJECTABLE;INJECTION >D> AP INGENUS PHARMS LLC 2MG/ML A 209315 002 Jan 14, 2021 Feb DISC >A> @ 2MG/ML A 209315 002 Jan 14, 2021 Feb DISC

>A> ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL ACETATE; VITAMIN A; VITAMIN K >A> INJECTABLE;INTRAVENOUS >A> INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE) >A> +! SANDOZ CANADA INC 80MG/VIAL;0.02MG/VIAL;400 N 021265 002 Jan 29, 2004 Feb CAIN IU/VIAL;0.001MG/VIAL;5MG/VIAL;0 .14MG/VIAL;17MG/VIAL;1MG/VIAL;1 .4MG/VIAL;1.2MG/VIAL;7 IU/VIAL;2,300 IU/VIAL;0.2MG/VIAL

>D> ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL HYDROCHLORIDE; VITAMIN A; VITAMIN K >D> INJECTABLE;INTRAVENOUS >D> INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE) >D> +! SANDOZ CANADA INC 80MG/VIAL;0.02MG/VIAL;400 N 021265 002 Jan 29, 2004 Feb CAIN IU/VIAL;0.001MG/VIAL;5MG/VIAL;0 .14MG/VIAL;17MG/VIAL;1MG/VIAL;1 .4MG/VIAL;1.2MG/VIAL;7 IU/VIAL;2,300 IU/VIAL;0.2MG/VIAL

ASENAPINE MALEATE TABLET;SUBLINGUAL ASENAPINE MALEATE >A> AB BRECKENRIDGE EQ 5MG BASE A 205960 003 Mar 08, 2021 Feb NEWA

ATOMOXETINE HYDROCHLORIDE CAPSULE;ORAL ATOMOXETINE HYDROCHLORIDE >A> @ MYLAN 10MG A 079021 001 Feb 18, 2021 Feb DISC >A> @ 18MG A 079021 002 Feb 18, 2021 Feb DISC >A> @ 25MG A 079021 003 Feb 18, 2021 Feb DISC

Page 2 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ATOMOXETINE HYDROCHLORIDE CAPSULE;ORAL ATOMOXETINE HYDROCHLORIDE >A> @ 40MG A 079021 004 Feb 18, 2021 Feb DISC >A> @ 60MG A 079021 005 Feb 18, 2021 Feb DISC >A> @ 80MG A 079021 006 Feb 18, 2021 Feb DISC >A> @ 100MG A 079021 007 Feb 18, 2021 Feb DISC

ATORVASTATIN CALCIUM; EZETIMIBE TABLET;ORAL LIPTRUZET >D> + @ MERCK SHARP DOHME EQ 10MG BASE;10MG N 200153 001 May 03, 2013 Feb CAHN >D> + @ EQ 20MG BASE;10MG N 200153 002 May 03, 2013 Feb CAHN >D> + @ EQ 40MG BASE;10MG N 200153 003 May 03, 2013 Feb CAHN >D> + @ EQ 80MG BASE;10MG N 200153 004 May 03, 2013 Feb CAHN >A> + @ ORGANON EQ 10MG BASE;10MG N 200153 001 May 03, 2013 Feb CAHN >A> + @ EQ 20MG BASE;10MG N 200153 002 May 03, 2013 Feb CAHN >A> + @ EQ 40MG BASE;10MG N 200153 003 May 03, 2013 Feb CAHN >A> + @ EQ 80MG BASE;10MG N 200153 004 May 03, 2013 Feb CAHN

AZELASTINE HYDROCHLORIDE; PROPIONATE SPRAY, METERED;NASAL AZELASTINE HYDROCHLORIDE AND >A> AB PERRIGO UK FINCO EQ 0.125MG A 208111 001 Feb 18, 2021 Feb NEWA BASE/SPRAY;0.05MG/SPRAY

AZITHROMYCIN FOR SUSPENSION;ORAL AZITHROMYCIN >D> @ TARO EQ 200MG BASE/5ML A 211521 001 Dec 11, 2019 Feb CMFD >A> AB EQ 200MG BASE/5ML A 211521 001 Dec 11, 2019 Feb CMFD INJECTABLE;INJECTION AZITHROMYCIN >D> AP MYLAN ASI EQ 500MG BASE/VIAL A 065506 001 Mar 24, 2009 Feb DISC >A> @ EQ 500MG BASE/VIAL A 065506 001 Mar 24, 2009 Feb DISC TABLET;ORAL AZITHROMYCIN >D> @ YUNG SHIN PHARM EQ 600MG BASE A 211068 001 May 08, 2020 Feb CMFD >A> AB EQ 600MG BASE A 211068 001 May 08, 2020 Feb CMFD

BACLOFEN TABLET;ORAL BACLOFEN >A> AB KARTHA 5MG A 214374 001 Mar 05, 2021 Feb NEWA >A> AB 10MG A 214374 002 Mar 05, 2021 Feb NEWA >A> AB 20MG A 214374 003 Mar 05, 2021 Feb NEWA

BENAZEPRIL HYDROCHLORIDE TABLET;ORAL LOTENSIN >D> AB + US PHARMS HOLDINGS I 5MG N 019851 001 Jun 25, 1991 Feb CAHN >D> AB + 10MG N 019851 002 Jun 25, 1991 Feb CAHN >D> AB + 20MG N 019851 003 Jun 25, 1991 Feb CAHN >D> AB +! 40MG N 019851 004 Jun 25, 1991 Feb CAHN >A> AB + VALIDUS PHARMS 5MG N 019851 001 Jun 25, 1991 Feb CAHN >A> AB + 10MG N 019851 002 Jun 25, 1991 Feb CAHN >A> AB + 20MG N 019851 003 Jun 25, 1991 Feb CAHN >A> AB +! 40MG N 019851 004 Jun 25, 1991 Feb CAHN

BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE TABLET;ORAL LOTENSIN HCT >D> + @ US PHARMS HOLDINGS I 5MG;6.25MG N 020033 001 May 19, 1992 Feb CAHN >D> AB + 10MG;12.5MG N 020033 002 May 19, 1992 Feb CAHN >D> AB + 20MG;12.5MG N 020033 004 May 19, 1992 Feb CAHN >D> AB +! 20MG;25MG N 020033 003 May 19, 1992 Feb CAHN >A> + @ VALIDUS PHARMS 5MG;6.25MG N 020033 001 May 19, 1992 Feb CAHN >A> AB + 10MG;12.5MG N 020033 002 May 19, 1992 Feb CAHN >A> AB + 20MG;12.5MG N 020033 004 May 19, 1992 Feb CAHN >A> AB +! 20MG;25MG N 020033 003 May 19, 1992 Feb CAHN

Page 3 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE LOTION;TOPICAL CLOTRIMAZOLE AND DIPROPIONATE >D> AB TARO EQ 0.05% BASE;1% A 076493 001 Jul 28, 2004 Feb CHRS >A> AB ! EQ 0.05% BASE;1% A 076493 001 Jul 28, 2004 Feb CHRS >D> LOTRISONE >D> AB +! MERCK SHARP DOHME EQ 0.05% BASE;1% N 020010 001 Dec 08, 2000 Feb DISC >A> + @ EQ 0.05% BASE;1% N 020010 001 Dec 08, 2000 Feb DISC

BIMATOPROST SOLUTION/DROPS;OPHTHALMIC BIMATOPROST >A> @ AKORN 0.03% A 203299 001 Nov 08, 2018 Feb CAHN >D> @ HI-TECH PHARMA CO 0.03% A 203299 001 Nov 08, 2018 Feb CAHN

BOSENTAN TABLET, FOR SUSPENSION;ORAL TRACLEER >A> +! ACTELION 32MG N 209279 001 Sep 05, 2017 Feb CAHN >D> +! ACTELION PHARMS 32MG N 209279 001 Sep 05, 2017 Feb CAHN TABLET;ORAL TRACLEER >A> AB + ACTELION 62.5MG N 021290 001 Nov 20, 2001 Feb CAHN >A> AB +! 125MG N 021290 002 Nov 20, 2001 Feb CAHN >D> AB + ACTELION PHARMS LTD 62.5MG N 021290 001 Nov 20, 2001 Feb CAHN >D> AB +! 125MG N 021290 002 Nov 20, 2001 Feb CAHN

BROMOCRIPTINE MESYLATE CAPSULE;ORAL PARLODEL >D> AB + US PHARMS HOLDINGS I EQ 5MG BASE N 017962 002 Mar 01, 1982 Feb CAHN >A> AB + VALIDUS PHARMS EQ 5MG BASE N 017962 002 Mar 01, 1982 Feb CAHN TABLET;ORAL PARLODEL >D> AB + US PHARMS HOLDINGS I EQ 2.5MG BASE N 017962 001 Jun 28, 1978 Feb CAHN >A> AB + VALIDUS PHARMS EQ 2.5MG BASE N 017962 001 Jun 28, 1978 Feb CAHN

BUPIVACAINE >A> SOLUTION, EXTENDED RELEASE;INFILTRATION >A> POSIMIR >A> +! DURECT 660MG/5ML (132MG/ML) N 204803 001 Feb 01, 2021 Feb NEWA

BUPIVACAINE HYDROCHLORIDE INJECTABLE;INJECTION BUPIVACAINE HYDROCHLORIDE >A> AP HIKMA PHARMS 0.25% A 205141 001 Feb 11, 2021 Feb NEWA >A> AP 0.5% A 205141 002 Feb 11, 2021 Feb NEWA BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE >A> AP HIKMA PHARMS 0.25% A 204842 001 Feb 11, 2021 Feb NEWA >A> AP 0.5% A 204842 002 Feb 11, 2021 Feb NEWA >A> AP 0.75% A 204842 003 Feb 11, 2021 Feb NEWA

BUPROPION HYDROBROMIDE TABLET, EXTENDED RELEASE;ORAL APLENZIN >A> + BAUSCH 174MG N 022108 001 Apr 23, 2008 Feb CAHN >A> + 348MG N 022108 002 Apr 23, 2008 Feb CAHN >A> +! 522MG N 022108 003 Apr 23, 2008 Feb CAHN >D> + VALEANT PHARMS NORTH 174MG N 022108 001 Apr 23, 2008 Feb CAHN >D> + 348MG N 022108 002 Apr 23, 2008 Feb CAHN >D> +! 522MG N 022108 003 Apr 23, 2008 Feb CAHN

BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL WELLBUTRIN XL >A> AB3 + BAUSCH 150MG N 021515 001 Aug 28, 2003 Feb CAHN >A> AB3 +! 300MG N 021515 002 Aug 28, 2003 Feb CAHN >D> AB3 + VALEANT INTL 150MG N 021515 001 Aug 28, 2003 Feb CAHN >D> AB3 +! 300MG N 021515 002 Aug 28, 2003 Feb CAHN

Page 4 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

BUSPIRONE HYDROCHLORIDE TABLET;ORAL BUSPIRONE HYDROCHLORIDE >D> @ RUBICON 5MG A 075521 001 Apr 05, 2002 Feb CMFD >A> AB 5MG A 075521 001 Apr 05, 2002 Feb CMFD >D> @ 10MG A 075521 002 Apr 05, 2002 Feb CMFD >A> AB 10MG A 075521 002 Apr 05, 2002 Feb CMFD >D> @ 15MG A 075521 003 Apr 05, 2002 Feb CMFD >A> AB 15MG A 075521 003 Apr 05, 2002 Feb CMFD

BUSULFAN INJECTABLE;INJECTION >A> AP AM REGENT 6MG/ML A 202259 001 Dec 22, 2015 Feb CAHN >D> AP LUITPOLD 6MG/ML A 202259 001 Dec 22, 2015 Feb CAHN

>A> CASIMERSEN >A> SOLUTION;INTRAVENOUS >A> AMONDYS 45 >A> +! SAREPTA THERAPS INC 100MG/2ML (50MG/ML) N 213026 001 Feb 25, 2021 Feb NEWA

CEFDINIR CAPSULE;ORAL CEFDINIR >A> AB ALKEM LABS LTD 300MG A 210220 001 Feb 19, 2021 Feb NEWA FOR SUSPENSION;ORAL CEFDINIR >A> AB ALKEM LABS LTD 125MG/5ML A 210534 001 Feb 19, 2021 Feb NEWA >A> AB 250MG/5ML A 210534 002 Feb 19, 2021 Feb NEWA

CEFIXIME FOR SUSPENSION;ORAL CEFIXIME >A> AB ALKEM LABS LTD 100MG/5ML A 211775 001 Feb 19, 2021 Feb NEWA >A> AB 200MG/5ML A 211775 002 Feb 19, 2021 Feb NEWA

CEFOTAXIME SODIUM INJECTABLE;INJECTION CLAFORAN >D> + @ US PHARM HOLDINGS EQ 500MG BASE/VIAL N 050547 001 Mar 11, 1981 Feb CAHN >D> + @ EQ 1GM BASE/VIAL N 050547 002 Mar 11, 1981 Feb CAHN >D> + @ EQ 2GM BASE/VIAL N 050547 003 Mar 11, 1981 Feb CAHN >D> + @ EQ 10GM BASE/VIAL N 050547 004 Dec 29, 1983 Feb CAHN >A> + @ VALIDUS PHARMS EQ 500MG BASE/VIAL N 050547 001 Mar 11, 1981 Feb CAHN >A> + @ EQ 1GM BASE/VIAL N 050547 002 Mar 11, 1981 Feb CAHN >A> + @ EQ 2GM BASE/VIAL N 050547 003 Mar 11, 1981 Feb CAHN >A> + @ EQ 10GM BASE/VIAL N 050547 004 Dec 29, 1983 Feb CAHN CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER >D> @ US PHARM HOLDINGS EQ 20MG BASE/ML N 050596 002 May 20, 1985 Feb CAHN >D> @ EQ 40MG BASE/ML N 050596 004 May 20, 1985 Feb CAHN >A> @ VALIDUS PHARMS EQ 20MG BASE/ML N 050596 002 May 20, 1985 Feb CAHN >A> @ EQ 40MG BASE/ML N 050596 004 May 20, 1985 Feb CAHN CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER >D> @ US PHARM HOLDINGS EQ 20MG BASE/ML N 050596 001 May 20, 1985 Feb CAHN >D> @ EQ 40MG BASE/ML N 050596 003 May 20, 1985 Feb CAHN >A> @ VALIDUS PHARMS EQ 20MG BASE/ML N 050596 001 May 20, 1985 Feb CAHN >A> @ EQ 40MG BASE/ML N 050596 003 May 20, 1985 Feb CAHN

CEFTAZIDIME SODIUM INJECTABLE;INJECTION FORTAZ IN PLASTIC CONTAINER >D> @ TELIGENT EQ 10MG BASE/ML N 050634 001 Apr 28, 1989 Feb CAHN >A> @ EQ 10MG BASE/ML N 050634 001 Apr 28, 1989 Feb CAHN >D> + @ EQ 20MG BASE/ML N 050634 002 Apr 28, 1989 Feb CAHN >A> + @ EQ 20MG BASE/ML N 050634 002 Apr 28, 1989 Feb CAHN >D> + @ EQ 40MG BASE/ML N 050634 003 Apr 28, 1989 Feb CAHN >A> + @ EQ 40MG BASE/ML N 050634 003 Apr 28, 1989 Feb CAHN

Page 5 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

CEFUROXIME SODIUM INJECTABLE;INJECTION ZINACEF >D> AP +! TELIGENT EQ 1.5GM BASE/VIAL N 050558 003 Oct 19, 1983 Feb CAHN >A> AP +! EQ 1.5GM BASE/VIAL N 050558 003 Oct 19, 1983 Feb CAHN >D> AP +! EQ 7.5GM BASE/VIAL N 050558 004 Oct 23, 1986 Feb CAHN >A> AP +! EQ 7.5GM BASE/VIAL N 050558 004 Oct 23, 1986 Feb CAHN INJECTABLE;INTRAMUSCULAR, INTRAVENOUS ZINACEF >D> AB +! TELIGENT EQ 750MG BASE/VIAL N 050558 002 Oct 19, 1983 Feb CAHN >A> AB +! EQ 750MG BASE/VIAL N 050558 002 Oct 19, 1983 Feb CAHN

CHLORHEXIDINE GLUCONATE SOLUTION;DENTAL CHLORHEXIDINE GLUCONATE >D> @ BAJAJ 0.12% A 075561 001 Nov 14, 2000 Feb CMFD >A> AT 0.12% A 075561 001 Nov 14, 2000 Feb CMFD

CHOLESTYRAMINE POWDER;ORAL CHOLESTYRAMINE >A> AB TAGI EQ 4GM RESIN/PACKET A 209597 001 Mar 09, 2021 Feb NEWA >A> AB EQ 4GM RESIN/SCOOPFUL A 209597 002 Mar 09, 2021 Feb NEWA

CIMETIDINE TABLET;ORAL CIMETIDINE >D> @ DAVA PHARMS INC 300MG A 074340 001 Jun 23, 1995 Feb CAHN >D> @ 400MG A 074340 002 Jun 23, 1995 Feb CAHN >D> @ 800MG A 074339 001 Jun 23, 1995 Feb CAHN >A> @ NOVITIUM PHARMA 300MG A 074340 001 Jun 23, 1995 Feb CAHN >A> @ 400MG A 074340 002 Jun 23, 1995 Feb CAHN >A> @ 800MG A 074339 001 Jun 23, 1995 Feb CAHN

CISATRACURIUM BESYLATE INJECTABLE;INJECTION CISATRACURIUM BESYLATE >D> AP ZYDUS PHARMS EQ 2MG BASE/ML A 213527 001 Aug 31, 2020 Feb DISC >A> @ EQ 2MG BASE/ML A 213527 001 Aug 31, 2020 Feb DISC

CLINDAMYCIN HYDROCHLORIDE CAPSULE;ORAL CLEOCIN HYDROCHLORIDE >A> AB + PFIZER EQ 75MG BASE N 050162 001 May 22, 1970 Feb CAHN >A> AB + EQ 150MG BASE N 050162 002 May 22, 1970 Feb CAHN >A> AB +! EQ 300MG BASE N 050162 003 Apr 14, 1988 Feb CAHN >D> AB + PHARMACIA AND UPJOHN EQ 75MG BASE N 050162 001 May 22, 1970 Feb CAHN >D> AB + EQ 150MG BASE N 050162 002 May 22, 1970 Feb CAHN >D> AB +! EQ 300MG BASE N 050162 003 Apr 14, 1988 Feb CAHN

CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR SOLUTION;ORAL CLEOCIN >A> AA ! PFIZER EQ 75MG BASE/5ML A 062644 001 Apr 07, 1986 Feb CAHN >D> AA ! PHARMACIA AND UPJOHN EQ 75MG BASE/5ML A 062644 001 Apr 07, 1986 Feb CAHN

CLINDAMYCIN PHOSPHATE CREAM;VAGINAL CLEOCIN >A> @ PFIZER EQ 2% BASE N 050680 001 Aug 11, 1992 Feb CAHN >A> AB +! EQ 2% BASE N 050680 002 Mar 02, 1998 Feb CAHN >D> @ PHARMACIA AND UPJOHN EQ 2% BASE N 050680 001 Aug 11, 1992 Feb CAHN >D> AB +! EQ 2% BASE N 050680 002 Mar 02, 1998 Feb CAHN GEL;TOPICAL CLEOCIN T >A> AB +! PFIZER EQ 1% BASE N 050615 001 Jan 07, 1987 Feb CAHN >D> AB +! PHARMACIA AND UPJOHN EQ 1% BASE N 050615 001 Jan 07, 1987 Feb CAHN INJECTABLE;INJECTION CLEOCIN PHOSPHATE >A> AP PFIZER EQ 150MG BASE/ML A 062803 001 Oct 16, 1987 Feb CAHN >A> AP +! EQ 150MG BASE/ML N 050441 001 Oct 02, 1972 Feb CAHN

Page 6 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

CLINDAMYCIN PHOSPHATE INJECTABLE;INJECTION CLEOCIN PHOSPHATE >D> AP PHARMACIA AND UPJOHN EQ 150MG BASE/ML A 062803 001 Oct 16, 1987 Feb CAHN >D> AP +! EQ 150MG BASE/ML N 050441 001 Oct 02, 1972 Feb CAHN CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER >A> + @ PFIZER EQ 6MG BASE/ML N 050639 001 Aug 30, 1989 Feb CAHN >A> + @ EQ 12MG BASE/ML N 050639 002 Aug 30, 1989 Feb CAHN >A> + @ EQ 18MG BASE/ML N 050639 003 Apr 10, 1991 Feb CAHN >D> + @ PHARMACIA AND UPJOHN EQ 6MG BASE/ML N 050639 001 Aug 30, 1989 Feb CAHN >D> + @ EQ 12MG BASE/ML N 050639 002 Aug 30, 1989 Feb CAHN >D> + @ EQ 18MG BASE/ML N 050639 003 Apr 10, 1991 Feb CAHN LOTION;TOPICAL CLEOCIN T >A> AB +! PFIZER EQ 1% BASE N 050600 001 May 31, 1989 Feb CAHN >D> AB +! PHARMACIA AND UPJOHN EQ 1% BASE N 050600 001 May 31, 1989 Feb CAHN CLINDAMYCIN PHOSPHATE >A> AB GAGE DEVELOPMENT EQ 1% BASE A 214604 001 Mar 08, 2021 Feb NEWA SOLUTION;TOPICAL CLEOCIN T >A> + @ PFIZER EQ 1% BASE N 050537 001 Jul 09, 1980 Feb CAHN >D> + @ PHARMACIA AND UPJOHN EQ 1% BASE N 050537 001 Jul 09, 1980 Feb CAHN SUPPOSITORY;VAGINAL CLEOCIN >A> +! PFIZER 100MG N 050767 001 Aug 13, 1999 Feb CAHN >D> +! PHARMACIA AND UPJOHN 100MG N 050767 001 Aug 13, 1999 Feb CAHN SWAB;TOPICAL CLEOCIN >A> AT +! PFIZER EQ 1% BASE N 050537 002 Feb 22, 1994 Feb CAHN >D> AT +! PHARMACIA AND UPJOHN EQ 1% BASE N 050537 002 Feb 22, 1994 Feb CAHN

CLOPIDOGREL BISULFATE TABLET;ORAL CLOPIDOGREL BISULFATE >D> @ POLYGEN PHARMS EQ 75MG BASE A 213351 001 Jul 17, 2020 Feb CMFD >A> AB EQ 75MG BASE A 213351 001 Jul 17, 2020 Feb CMFD >D> @ EQ 300MG BASE A 213351 002 Jul 17, 2020 Feb CMFD >A> AB EQ 300MG BASE A 213351 002 Jul 17, 2020 Feb CMFD

CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; HYDROCHLORIDE SYRUP;ORAL PROMETHAZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE >A> AA AKORN 10MG/5ML;5MG/5ML;6.25MG/5ML A 040674 001 Dec 23, 2014 Feb CAHN >D> AA HI-TECH PHARMA CO 10MG/5ML;5MG/5ML;6.25MG/5ML A 040674 001 Dec 23, 2014 Feb CAHN

COLESEVELAM HYDROCHLORIDE FOR SUSPENSION;ORAL COLESEVELAM HYDROCHLORIDE >D> AB GLENMARK PHARMS LTD 1.875GM/PACKET A 202190 001 Jul 16, 2018 Feb CTEC >A> 1.875GM/PACKET A 202190 001 Jul 16, 2018 Feb CTEC >D> AB WATSON LABS INC 1.875GM/PACKET A 202178 001 Sep 01, 2020 Feb DISC >A> @ 1.875GM/PACKET A 202178 001 Sep 01, 2020 Feb DISC >D> AB 3.75GM/PACKET A 202178 002 Sep 01, 2020 Feb DISC >A> @ 3.75GM/PACKET A 202178 002 Sep 01, 2020 Feb DISC TABLET;ORAL COLESEVELAM HYDROCHLORIDE >D> AB WATSON LABS INC 625MG A 200830 001 Sep 02, 2020 Feb DISC >A> @ 625MG A 200830 001 Sep 02, 2020 Feb DISC

COLESTIPOL HYDROCHLORIDE GRANULE;ORAL COLESTID >A> AB + PFIZER 5GM/SCOOPFUL N 017563 003 Sep 22, 1995 Feb CAHN >A> AB +! 5GM/PACKET N 017563 004 Sep 22, 1995 Feb CAHN >D> AB + PHARMACIA UPJOHN 5GM/SCOOPFUL N 017563 003 Sep 22, 1995 Feb CAHN >D> AB +! 5GM/PACKET N 017563 004 Sep 22, 1995 Feb CAHN FLAVORED COLESTID >A> + PFIZER 5GM/PACKET N 017563 001 Apr 04, 1977 Feb CAHN >A> + 5GM/SCOOPFUL N 017563 002 Apr 04, 1977 Feb CAHN >D> + PHARMACIA UPJOHN 5GM/PACKET N 017563 001 Apr 04, 1977 Feb CAHN

Page 7 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

COLESTIPOL HYDROCHLORIDE GRANULE;ORAL FLAVORED COLESTID >D> + 5GM/SCOOPFUL N 017563 002 Apr 04, 1977 Feb CAHN TABLET;ORAL COLESTID >A> AB +! PFIZER 1GM N 020222 001 Jul 19, 1994 Feb CAHN >D> AB +! PHARMACIA UPJOHN 1GM N 020222 001 Jul 19, 1994 Feb CAHN

CYPROHEPTADINE HYDROCHLORIDE TABLET;ORAL HYDROCHLORIDE >A> AA QUAGEN 4MG A 212491 001 Feb 24, 2021 Feb NEWA

DACTINOMYCIN INJECTABLE;INJECTION >D> AP HONG KONG 0.5MG/VIAL A 213463 001 Nov 13, 2020 Feb CAHN >A> AP MEITHEAL 0.5MG/VIAL A 213463 001 Nov 13, 2020 Feb CAHN

DEFERASIROX GRANULE;ORAL DEFERASIROX >A> AB AUCTA 90MG A 214559 001 Mar 09, 2021 Feb NEWA >A> AB 180MG A 214559 002 Mar 09, 2021 Feb NEWA >A> AB 360MG A 214559 003 Mar 09, 2021 Feb NEWA

DESIPRAMINE HYDROCHLORIDE TABLET;ORAL NORPRAMIN >D> AB + US PHARM HOLDINGS 10MG N 014399 007 Feb 11, 1982 Feb CAHN >D> AB + 25MG N 014399 001 Nov 20, 1964 Feb CAHN >D> AB + 50MG N 014399 003 Jan 09, 1967 Feb CAHN >D> AB + 75MG N 014399 004 Mar 01, 1977 Feb CAHN >D> AB +! 100MG N 014399 005 Mar 01, 1977 Feb CAHN >D> AB + 150MG N 014399 006 Mar 01, 1977 Feb CAHN >A> AB + VALIDUS PHARMS 10MG N 014399 007 Feb 11, 1982 Feb CAHN >A> AB + 25MG N 014399 001 Nov 20, 1964 Feb CAHN >A> AB + 50MG N 014399 003 Jan 09, 1967 Feb CAHN >A> AB + 75MG N 014399 004 Mar 01, 1977 Feb CAHN >A> AB +! 100MG N 014399 005 Mar 01, 1977 Feb CAHN >A> AB + 150MG N 014399 006 Mar 01, 1977 Feb CAHN

DESMOPRESSIN ACETATE SPRAY, METERED;NASAL NOCTIVA >D> + @ ALYVANT 0.00083MG/SPRAY N 201656 001 Mar 03, 2017 Feb CAHN >D> + @ 0.00166MG/SPRAY N 201656 002 Mar 03, 2017 Feb CAHN >A> + @ ROIVANT 0.00083MG/SPRAY N 201656 001 Mar 03, 2017 Feb CAHN >A> + @ 0.00166MG/SPRAY N 201656 002 Mar 03, 2017 Feb CAHN

DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE INJECTABLE;INJECTION POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% >A> AP FRESENIUS KABI USA 5GM/100ML;74.5MG/100ML;450MG/10 A 213523 001 Mar 09, 2021 Feb NEWA 0ML POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% >A> AP FRESENIUS KABI USA 5GM/100ML;149MG/100ML;450MG/100 A 213523 002 Mar 09, 2021 Feb NEWA ML POTASSIUM CHLORIDE 20MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% >A> AP FRESENIUS KABI USA 5GM/100ML;149MG/100ML;900MG/100 A 213445 001 Mar 09, 2021 Feb NFTG ML POTASSIUM CHLORIDE 30MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% >A> AP FRESENIUS KABI USA 5GM/100ML;224MG/100ML;450MG/100 A 213523 003 Mar 09, 2021 Feb NEWA ML POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45% >A> AP FRESENIUS KABI USA 5GM/100ML;298MG/100ML;450MG/100 A 213523 004 Mar 09, 2021 Feb NEWA ML POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% >A> AP FRESENIUS KABI USA 5GM/100ML;298MG/100ML;900MG/100 A 213445 002 Mar 09, 2021 Feb NFTG ML

Page 8 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

DEXTROSE; SODIUM CHLORIDE INJECTABLE;INJECTION DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER >D> AP FRESENIUS KABI USA 5GM/100ML;300MG/100ML A 211194 001 Aug 26, 2020 Feb DISC >A> @ 5GM/100ML;300MG/100ML A 211194 001 Aug 26, 2020 Feb DISC >D> AP +! ICU MEDICAL INC 5GM/100ML;300MG/100ML N 017799 001 Apr 12, 1977 Feb CTEC >A> +! 5GM/100ML;300MG/100ML N 017799 001 Apr 12, 1977 Feb CTEC

DICLOFENAC SODIUM TABLET, DELAYED RELEASE;ORAL DICLOFENAC SODIUM >A> @ MICRO LABS 50MG A 074986 001 Feb 26, 1999 Feb CAHN >A> @ 75MG A 074986 002 Feb 26, 1999 Feb CAHN >D> @ MICRO LABS USA 50MG A 074986 001 Feb 26, 1999 Feb CAHN >D> @ 75MG A 074986 002 Feb 26, 1999 Feb CAHN

DIMETHYL FUMARATE CAPSULE, DELAYED RELEASE;ORAL DIMETHYL FUMARATE >D> AB ZYDUS PHARMS 120MG A 210538 001 Sep 24, 2020 Feb DISC >A> @ 120MG A 210538 001 Sep 24, 2020 Feb DISC >D> AB 240MG A 210538 002 Sep 24, 2020 Feb DISC >A> @ 240MG A 210538 002 Sep 24, 2020 Feb DISC

DISOPYRAMIDE PHOSPHATE CAPSULE;ORAL DISOPYRAMIDE PHOSPHATE >D> AB MAYNE PHARMA EQ 100MG BASE A 070173 001 May 31, 1985 Feb DISC >A> @ EQ 100MG BASE A 070173 001 May 31, 1985 Feb DISC >D> AB EQ 150MG BASE A 070173 002 May 31, 1985 Feb DISC >A> @ EQ 150MG BASE A 070173 002 May 31, 1985 Feb DISC

DOFETILIDE CAPSULE;ORAL DOFETILIDE >D> AB RICONPHARMA LLC 0.125MG A 212410 001 Dec 27, 2019 Feb DISC >A> @ 0.125MG A 212410 001 Dec 27, 2019 Feb DISC >D> AB 0.25MG A 212410 002 Dec 27, 2019 Feb DISC >A> @ 0.25MG A 212410 002 Dec 27, 2019 Feb DISC >D> AB 0.5MG A 212410 003 Dec 27, 2019 Feb DISC >A> @ 0.5MG A 212410 003 Dec 27, 2019 Feb DISC

DOLASETRON MESYLATE INJECTABLE;INJECTION ANZEMET >D> + @ US PHARM HOLDINGS 12.5MG/0.625ML (20MG/ML) N 020624 002 Sep 11, 1997 Feb CAHN >D> + @ 100MG/5ML (20MG/ML) N 020624 001 Sep 11, 1997 Feb CAHN >D> @ 500MG/25ML (20MG/ML) N 020624 003 Dec 11, 2001 Feb CAHN >A> + @ VALIDUS PHARMS 12.5MG/0.625ML (20MG/ML) N 020624 002 Sep 11, 1997 Feb CAHN >A> + @ 100MG/5ML (20MG/ML) N 020624 001 Sep 11, 1997 Feb CAHN >A> @ 500MG/25ML (20MG/ML) N 020624 003 Dec 11, 2001 Feb CAHN TABLET;ORAL ANZEMET >D> + @ US PHARM HOLDINGS 50MG N 020623 001 Sep 11, 1997 Feb CAHN >D> + @ 100MG N 020623 002 Sep 11, 1997 Feb CAHN >A> + @ VALIDUS PHARMS 50MG N 020623 001 Sep 11, 1997 Feb CAHN >A> + @ 100MG N 020623 002 Sep 11, 1997 Feb CAHN

DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE SOLUTION/DROPS;OPHTHALMIC DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE >D> @ FDC LTD EQ 2% BASE;EQ 0.5% BASE A 205295 001 Jun 13, 2019 Feb CMFD >A> AT EQ 2% BASE;EQ 0.5% BASE A 205295 001 Jun 13, 2019 Feb CMFD

DOXEPIN HYDROCHLORIDE CAPSULE;ORAL HYDROCHLORIDE >A> AB LEADING PHARMA LLC EQ 10MG BASE A 211619 001 Mar 09, 2021 Feb NEWA >A> AB EQ 25MG BASE A 211619 002 Mar 09, 2021 Feb NEWA >A> AB EQ 50MG BASE A 211619 003 Mar 09, 2021 Feb NEWA

Page 9 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

DOXEPIN HYDROCHLORIDE CAPSULE;ORAL DOXEPIN HYDROCHLORIDE >A> AB EQ 75MG BASE A 211619 004 Mar 09, 2021 Feb NEWA >A> AB EQ 100MG BASE A 211619 005 Mar 09, 2021 Feb NEWA >A> AB EQ 150MG BASE A 211618 001 Mar 01, 2021 Feb NEWA >D> AB UPSHER SMITH LABS EQ 10MG BASE A 210268 001 Sep 04, 2020 Feb DISC >A> @ EQ 10MG BASE A 210268 001 Sep 04, 2020 Feb DISC >D> AB EQ 25MG BASE A 210268 002 Sep 04, 2020 Feb DISC >A> @ EQ 25MG BASE A 210268 002 Sep 04, 2020 Feb DISC >D> AB EQ 50MG BASE A 210268 003 Sep 04, 2020 Feb DISC >A> @ EQ 50MG BASE A 210268 003 Sep 04, 2020 Feb DISC >D> AB EQ 75MG BASE A 210268 004 Sep 04, 2020 Feb DISC >A> @ EQ 75MG BASE A 210268 004 Sep 04, 2020 Feb DISC >D> AB EQ 100MG BASE A 210268 005 Sep 04, 2020 Feb DISC >A> @ EQ 100MG BASE A 210268 005 Sep 04, 2020 Feb DISC

DOXYCYCLINE HYCLATE TABLET;ORAL DOXYCYCLINE HYCLATE >A> AB ORYZA EQ 100MG BASE A 213475 001 Mar 10, 2021 Feb NEWA

DROXIDOPA CAPSULE;ORAL >A> DROXIDOPA >A> AB AJANTA PHARMA LTD 100MG A 214391 001 Feb 18, 2021 Feb NFTG >A> AB 200MG A 214391 002 Feb 18, 2021 Feb NFTG >A> AB 300MG A 214391 003 Feb 18, 2021 Feb NFTG >A> AB ALKEM LABS LTD 100MG A 213911 001 Feb 18, 2021 Feb NFTG >A> AB 200MG A 213911 002 Feb 18, 2021 Feb NFTG >A> AB 300MG A 213911 003 Feb 18, 2021 Feb NFTG >A> AB ANNORA 300MG A 211726 001 Feb 18, 2021 Feb NFTG >A> AB AUROBINDO PHARMA LTD 100MG A 214387 001 Feb 18, 2021 Feb NFTG >A> AB 200MG A 214387 002 Feb 18, 2021 Feb NFTG >A> AB 300MG A 214387 003 Feb 18, 2021 Feb NFTG >A> AB HIKMA 100MG A 212835 001 Feb 18, 2021 Feb NFTG >A> AB 200MG A 212835 002 Feb 18, 2021 Feb NFTG >A> AB 300MG A 212835 003 Feb 18, 2021 Feb NFTG >A> AB LUPIN PHARMS 100MG A 211652 001 Feb 18, 2021 Feb NFTG >A> AB 200MG A 211652 002 Feb 18, 2021 Feb NFTG >A> AB 300MG A 211652 003 Feb 18, 2021 Feb NFTG >A> AB MSN PHARMS INC 100MG A 211741 001 Feb 18, 2021 Feb NFTG >A> AB 200MG A 211741 002 Feb 18, 2021 Feb NFTG >A> AB 300MG A 211741 003 Feb 18, 2021 Feb NFTG >A> AB SCIEGEN PHARMS INC 100MG A 214017 001 Feb 18, 2021 Feb NFTG >A> AB 200MG A 214017 002 Feb 18, 2021 Feb NFTG >A> AB 300MG A 214017 003 Feb 18, 2021 Feb NFTG >A> AB SUN PHARM 100MG A 214384 001 Feb 18, 2021 Feb NFTG >A> AB 200MG A 214384 002 Feb 18, 2021 Feb NFTG >A> AB 300MG A 214384 003 Feb 18, 2021 Feb NFTG >A> AB TASMAN PHARMA 100MG A 213661 001 Feb 18, 2021 Feb NFTG >A> AB 200MG A 213661 002 Feb 18, 2021 Feb NFTG >A> AB 300MG A 213661 003 Feb 18, 2021 Feb NFTG >A> AB TEVA PHARMS USA INC 100MG A 213162 001 Feb 18, 2021 Feb NFTG >A> AB 200MG A 213162 002 Feb 18, 2021 Feb NFTG >A> AB 300MG A 213162 003 Feb 18, 2021 Feb NFTG >A> AB ZYDUS PHARMS 100MG A 211818 001 Feb 18, 2021 Feb NFTG >A> AB 200MG A 211818 002 Feb 18, 2021 Feb NFTG >A> AB 300MG A 211818 003 Feb 18, 2021 Feb NFTG

DULOXETINE HYDROCHLORIDE CAPSULE, DELAYED REL PELLETS;ORAL DULOXETINE HYDROCHLORIDE >A> AB SUNSHINE EQ 20MG BASE A 212328 001 Feb 11, 2021 Feb NEWA >A> AB EQ 30MG BASE A 212328 002 Feb 11, 2021 Feb NEWA >A> AB EQ 60MG BASE A 212328 003 Feb 11, 2021 Feb NEWA

Page 10 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ECONAZOLE NITRATE AEROSOL, FOAM;TOPICAL ECOZA >D> +! GLENMARK 1% N 205175 001 Oct 24, 2013 Feb CAHN >A> +! RESILIA PHARMS 1% N 205175 001 Oct 24, 2013 Feb CAHN

EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE >D> +! AUROBINDO PHARMA LTD 600MG;300MG;300MG N 022343 001 Aug 15, 2018 Feb DISC >A> + @ 600MG;300MG;300MG N 022343 001 Aug 15, 2018 Feb DISC

EFINACONAZOLE SOLUTION;TOPICAL EFINACONAZOLE >D> AT TEVA PHARMS USA 10% A 211827 001 Dec 16, 2020 Feb CTEC >A> AB 10% A 211827 001 Dec 16, 2020 Feb CTEC JUBLIA >D> AT +! BAUSCH 10% N 203567 001 Jun 06, 2014 Feb CTEC >A> AB +! 10% N 203567 001 Jun 06, 2014 Feb CTEC

EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE >D> @ MACLEODS PHARMS LTD 200MG;300MG A 203442 001 May 15, 2020 Feb CMFD >A> AB 200MG;300MG A 203442 001 May 15, 2020 Feb CMFD >D> @ MYLAN 200MG;300MG A 206436 001 Apr 09, 2018 Feb CMFD >A> AB 200MG;300MG A 206436 001 Apr 09, 2018 Feb CMFD

EPLERENONE TABLET;ORAL EPLERENONE >D> AB PIRAMAL HLTHCARE UK 25MG A 212765 001 Aug 10, 2020 Feb DISC >A> @ 25MG A 212765 001 Aug 10, 2020 Feb DISC >D> AB 50MG A 212765 002 Aug 10, 2020 Feb DISC >A> @ 50MG A 212765 002 Aug 10, 2020 Feb DISC

EPOPROSTENOL SODIUM INJECTABLE;INJECTION EPOPROSTENOL SODIUM >D> AP SUN PHARM EQ 0.5MG BASE/VIAL A 210473 001 Jan 15, 2021 Feb CTEC >A> AP2 EQ 0.5MG BASE/VIAL A 210473 001 Jan 15, 2021 Feb CTEC >D> AP EQ 1.5MG BASE/VIAL A 210473 002 Jan 15, 2021 Feb CTEC >A> AP2 EQ 1.5MG BASE/VIAL A 210473 002 Jan 15, 2021 Feb CTEC >D> AP TEVA PHARMS USA EQ 0.5MG BASE/VIAL A 078396 001 Apr 23, 2008 Feb CTEC >A> AP1 EQ 0.5MG BASE/VIAL A 078396 001 Apr 23, 2008 Feb CTEC >D> AP EQ 1.5MG BASE/VIAL A 078396 002 Apr 23, 2008 Feb CTEC >A> AP1 EQ 1.5MG BASE/VIAL A 078396 002 Apr 23, 2008 Feb CTEC FLOLAN >D> AP +! GLAXOSMITHKLINE LLC EQ 0.5MG BASE/VIAL N 020444 001 Sep 20, 1995 Feb CTEC >A> AP1 +! EQ 0.5MG BASE/VIAL N 020444 001 Sep 20, 1995 Feb CTEC >D> AP +! EQ 1.5MG BASE/VIAL N 020444 002 Sep 20, 1995 Feb CTEC >A> AP1 +! EQ 1.5MG BASE/VIAL N 020444 002 Sep 20, 1995 Feb CTEC VELETRI >A> AP2 +! ACTELION EQ 0.5MG BASE/VIAL N 022260 002 Jun 28, 2012 Feb CAHN >A> AP2 +! EQ 1.5MG BASE/VIAL N 022260 001 Jun 27, 2008 Feb CAHN >D> AP + ACTELION PHARMS LTD EQ 0.5MG BASE/VIAL N 022260 002 Jun 28, 2012 Feb CAHN >D> AP +! EQ 1.5MG BASE/VIAL N 022260 001 Jun 27, 2008 Feb CAHN

ERGOCALCIFEROL CAPSULE;ORAL DRISDOL >D> AA +! US PHARM HOLDINGS 50,000 IU N 003444 001 Jan 11, 1941 Feb CAHN >A> AA +! VALIDUS PHARMS 50,000 IU N 003444 001 Jan 11, 1941 Feb CAHN

Page 11 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ERYTHROMYCIN TABLET;ORAL ERYTHROMYCIN >A> AB TEVA PHARMS USA INC 250MG A 214549 001 Feb 11, 2021 Feb NEWA >A> AB 500MG A 214549 002 Feb 11, 2021 Feb NEWA

ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED REL PELLETS;ORAL ESOMEPRAZOLE MAGNESIUM >A> AB INDCHEMIE HEALTH EQ 20MG BASE A 210559 001 Feb 26, 2021 Feb NEWA >A> AB EQ 40MG BASE A 210559 002 Feb 26, 2021 Feb NEWA

ETHINYL ESTRADIOL; NORELGESTROMIN FILM, EXTENDED RELEASE;TRANSDERMAL ETHINYL ESTRADIOL AND NORELGESTROMIN >A> AB AMNEAL 0.035MG/24HR;0.15MG/24HR A 213950 001 Feb 25, 2021 Feb NEWA XULANE >D> ! MYLAN TECHNOLOGIES 0.035MG/24HR;0.15MG/24HR A 200910 001 Apr 16, 2014 Feb CTEC >A> AB ! 0.035MG/24HR;0.15MG/24HR A 200910 001 Apr 16, 2014 Feb CTEC

EVEROLIMUS TABLET;ORAL AFINITOR >D> + NOVARTIS 10MG N 022334 002 Mar 30, 2009 Feb CTEC >A> AB + 10MG N 022334 002 Mar 30, 2009 Feb CTEC EVEROLIMUS >A> @ BIOCON PHARMA 2.5MG A 214182 001 Feb 11, 2021 Feb DISC >A> @ 5MG A 214182 002 Feb 11, 2021 Feb DISC >A> @ 7.5MG A 214182 003 Feb 11, 2021 Feb DISC >A> @ 10MG A 214182 004 Feb 11, 2021 Feb DISC >A> AB BRECKENRIDGE 2.5MG A 205426 001 Mar 05, 2021 Feb NEWA >A> AB 5MG A 205426 002 Mar 05, 2021 Feb NEWA >A> AB 7.5MG A 205426 003 Mar 05, 2021 Feb NEWA >A> AB 10MG A 205426 004 Mar 05, 2021 Feb NEWA

EXENATIDE SYNTHETIC >D> FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS >D> BYDUREON >D> +! ASTRAZENECA AB 2MG/VIAL N 022200 001 Jan 27, 2012 Feb DISC >A> + @ 2MG/VIAL N 022200 001 Jan 27, 2012 Feb DISC >D> BYDUREON PEN >D> +! ASTRAZENECA AB 2MG N 022200 002 Feb 28, 2014 Feb DISC >A> + @ 2MG N 022200 002 Feb 28, 2014 Feb DISC

EZETIMIBE TABLET;ORAL ZETIA >D> AB +! MSD INTL GMBH 10MG N 021445 001 Oct 25, 2002 Feb CAHN >A> AB +! ORGANON 10MG N 021445 001 Oct 25, 2002 Feb CAHN

EZETIMIBE; SIMVASTATIN TABLET;ORAL VYTORIN >D> AB + MSD INTL 10MG;10MG N 021687 001 Jul 23, 2004 Feb CAHN >D> AB + 10MG;20MG N 021687 002 Jul 23, 2004 Feb CAHN >D> AB + 10MG;40MG N 021687 003 Jul 23, 2004 Feb CAHN >D> AB +! 10MG;80MG N 021687 004 Jul 23, 2004 Feb CAHN >A> AB + ORGANON 10MG;10MG N 021687 001 Jul 23, 2004 Feb CAHN >A> AB + 10MG;20MG N 021687 002 Jul 23, 2004 Feb CAHN >A> AB + 10MG;40MG N 021687 003 Jul 23, 2004 Feb CAHN >A> AB +! 10MG;80MG N 021687 004 Jul 23, 2004 Feb CAHN

FAMOTIDINE FOR SUSPENSION;ORAL FAMOTIDINE >A> AB AKORN 40MG/5ML A 201995 001 May 30, 2014 Feb CAHN >D> AB HI-TECH PHARMA CO 40MG/5ML A 201995 001 May 30, 2014 Feb CAHN

Page 12 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

FINGOLIMOD HYDROCHLORIDE CAPSULE;ORAL FINGOLIMOD HYDROCHLORIDE >A> AB DR REDDYS EQ 0.5MG BASE A 208000 001 Mar 05, 2021 Feb NEWA

FLUOXETINE HYDROCHLORIDE CAPSULE;ORAL FLUOXETINE HYDROCHLORIDE >D> AB1 ACCORD HLTHCARE EQ 10MG BASE A 202729 001 Aug 27, 2020 Feb DISC >A> @ EQ 10MG BASE A 202729 001 Aug 27, 2020 Feb DISC >D> AB1 EQ 20MG BASE A 202729 002 Aug 27, 2020 Feb DISC >A> @ EQ 20MG BASE A 202729 002 Aug 27, 2020 Feb DISC >D> AB EQ 40MG BASE A 202729 003 Aug 27, 2020 Feb DISC >A> @ EQ 40MG BASE A 202729 003 Aug 27, 2020 Feb DISC

FLUPHENAZINE HYDROCHLORIDE TABLET;ORAL FLUPHENAZINE HYDROCHLORIDE >A> AB NOVITIUM PHARMA 1MG A 214674 001 Mar 01, 2021 Feb NEWA >A> AB 2.5MG A 214674 002 Mar 01, 2021 Feb NEWA >A> AB 5MG A 214674 003 Mar 01, 2021 Feb NEWA >A> AB 10MG A 214674 004 Mar 01, 2021 Feb NEWA

FLUVOXAMINE MALEATE CAPSULE, EXTENDED RELEASE;ORAL FLUVOXAMINE MALEATE >D> AB BIONPHARMA INC 100MG A 212182 002 Sep 16, 2020 Feb DISC >A> @ 100MG A 212182 002 Sep 16, 2020 Feb DISC

FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS FOSAPREPITANT DIMEGLUMINE >A> AP CHIA TAI TIANQING EQ 150MG BASE/VIAL A 212143 001 Mar 03, 2021 Feb NEWA

>A> FOSDENOPTERIN HYDROBROMIDE >A> POWDER;INTRAVENOUS >A> NULIBRY >A> +! ORIGIN EQ 9.5MG BASE/VIAL N 214018 001 Feb 26, 2021 Feb NEWA

FUROSEMIDE TABLET;ORAL LASIX >D> AB + US PHARM HOLDINGS 20MG N 016273 002 May 07, 1974 Feb CAHN >D> AB + 40MG N 016273 001 Jul 01, 1966 Feb CAHN >D> AB +! 80MG N 016273 003 Apr 24, 1978 Feb CAHN >A> AB + VALIDUS PHARMS 20MG N 016273 002 May 07, 1974 Feb CAHN >A> AB + 40MG N 016273 001 Jul 01, 1966 Feb CAHN >A> AB +! 80MG N 016273 003 Apr 24, 1978 Feb CAHN

GABAPENTIN CAPSULE;ORAL GABAPENTIN >D> AB ZHEJIANG YONGTAI 100MG A 213603 001 Aug 17, 2020 Feb DISC >A> @ 100MG A 213603 001 Aug 17, 2020 Feb DISC >D> AB 300MG A 213603 002 Aug 17, 2020 Feb DISC >A> @ 300MG A 213603 002 Aug 17, 2020 Feb DISC >D> AB 400MG A 213603 003 Aug 17, 2020 Feb DISC >A> @ 400MG A 213603 003 Aug 17, 2020 Feb DISC

GATIFLOXACIN SOLUTION/DROPS;OPHTHALMIC GATIFLOXACIN >A> AT AKORN 0.5% A 203189 001 Sep 03, 2014 Feb CAHN >D> AT HI-TECH PHARMA CO 0.5% A 203189 001 Sep 03, 2014 Feb CAHN

GEMCITABINE HYDROCHLORIDE INJECTABLE;INJECTION HYDROCHLORIDE >D> AP JIANGSU HANSOH PHARM EQ 200MG BASE/VIAL A 202485 001 May 07, 2013 Feb CHRS >A> AP ! EQ 200MG BASE/VIAL A 202485 001 May 07, 2013 Feb CHRS >D> AP EQ 1GM BASE/VIAL A 202485 002 May 07, 2013 Feb CHRS

Page 13 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

GEMCITABINE HYDROCHLORIDE INJECTABLE;INJECTION GEMCITABINE HYDROCHLORIDE >A> AP ! EQ 1GM BASE/VIAL A 202485 002 May 07, 2013 Feb CHRS >D> GEMZAR >D> AP +! LILLY EQ 200MG BASE/VIAL N 020509 001 May 15, 1996 Feb DISC >A> + @ EQ 200MG BASE/VIAL N 020509 001 May 15, 1996 Feb DISC >D> AP +! EQ 1GM BASE/VIAL N 020509 002 May 15, 1996 Feb DISC >A> + @ EQ 1GM BASE/VIAL N 020509 002 May 15, 1996 Feb DISC

GLYBURIDE TABLET;ORAL GLYNASE >A> AB + PFIZER 1.5MG N 020051 001 Mar 04, 1992 Feb CAHN >A> AB + 3MG N 020051 002 Mar 04, 1992 Feb CAHN >A> + @ 4.5MG N 020051 003 Sep 24, 1993 Feb CAHN >A> AB +! 6MG N 020051 004 Sep 24, 1993 Feb CAHN >D> AB + PHARMACIA AND UPJOHN 1.5MG N 020051 001 Mar 04, 1992 Feb CAHN >D> AB + 3MG N 020051 002 Mar 04, 1992 Feb CAHN >D> + @ 4.5MG N 020051 003 Sep 24, 1993 Feb CAHN >D> AB +! 6MG N 020051 004 Sep 24, 1993 Feb CAHN MICRONASE >A> + @ PFIZER 1.25MG N 017498 001 May 01, 1984 Feb CAHN >A> @ 2.5MG N 017498 002 May 01, 1984 Feb CAHN >A> + @ 5MG N 017498 003 May 01, 1984 Feb CAHN >D> + @ PHARMACIA AND UPJOHN 1.25MG N 017498 001 May 01, 1984 Feb CAHN >D> @ 2.5MG N 017498 002 May 01, 1984 Feb CAHN >D> + @ 5MG N 017498 003 May 01, 1984 Feb CAHN

GLYCOPYRROLATE INJECTABLE;INJECTION GLYCOPYRROLATE >A> AP XIROMED 0.2MG/ML A 212227 001 Mar 04, 2021 Feb NEWA

GUANFACINE HYDROCHLORIDE TABLET;ORAL GUANFACINE HYDROCHLORIDE >A> AB UNICHEM EQ 1MG BASE A 214689 001 Mar 03, 2021 Feb NEWA >A> AB EQ 2MG BASE A 214689 002 Mar 03, 2021 Feb NEWA

HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE TABLET;ORAL LOPRESSOR HCT >D> AB + US PHARMS HOLDINGS I 25MG;50MG N 018303 001 Dec 31, 1984 Feb CAHN >D> + @ 25MG;100MG N 018303 002 Dec 31, 1984 Feb CAHN >D> + @ 50MG;100MG N 018303 003 Dec 31, 1984 Feb CAHN >A> AB + VALIDUS PHARMS 25MG;50MG N 018303 001 Dec 31, 1984 Feb CAHN >A> + @ 25MG;100MG N 018303 002 Dec 31, 1984 Feb CAHN >A> + @ 50MG;100MG N 018303 003 Dec 31, 1984 Feb CAHN

HYDROCODONE BITARTRATE TABLET, EXTENDED RELEASE;ORAL >A> HYDROCODONE BITARTRATE >A> AB ALVOGEN PINE BROOK 20MG A 208269 001 Mar 01, 2021 Feb NFTG >A> AB 30MG A 208269 002 Mar 01, 2021 Feb NFTG >A> AB 40MG A 208269 003 Mar 01, 2021 Feb NFTG >A> AB 60MG A 208269 004 Mar 01, 2021 Feb NFTG >A> AB 80MG A 208269 005 Mar 01, 2021 Feb NFTG >A> AB 100MG A 208269 006 Mar 01, 2021 Feb NFTG >A> AB 120MG A 208269 007 Mar 01, 2021 Feb NFTG

HYDROCORTISONE SODIUM PHOSPHATE INJECTABLE;INJECTION HYDROCORTONE >D> @ MERCK EQ 50MG BASE/ML N 012052 001 Jun 08, 1960 Feb CRLD >A> + @ EQ 50MG BASE/ML N 012052 001 Jun 08, 1960 Feb CRLD

Page 14 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

HYDROCORTISONE VALERATE CREAM;TOPICAL HYDROCORTISONE VALERATE >A> AB COSETTE 0.2% A 213724 001 Feb 11, 2021 Feb NEWA

HYDROXYZINE HYDROCHLORIDE TABLET;ORAL HYDROXYZINE HYDROCHLORIDE >A> AB PRINSTON INC 10MG A 040580 003 May 27, 2005 Feb CMS1 >A> AB 25MG A 040580 002 May 27, 2005 Feb CMS1

IBUPROFEN TABLET;ORAL IBUPROFEN >D> AB VINTAGE PHARMS 400MG A 071644 001 Feb 01, 1988 Feb DISC >A> @ 400MG A 071644 001 Feb 01, 1988 Feb DISC

IBUTILIDE FUMARATE INJECTABLE;INJECTION CORVERT >A> AP +! PFIZER 0.1MG/ML N 020491 001 Dec 28, 1995 Feb CAHN >D> AP +! PHARMACIA AND UPJOHN 0.1MG/ML N 020491 001 Dec 28, 1995 Feb CAHN

ILOPROST SOLUTION;INHALATION VENTAVIS >A> +! ACTELION 10MCG/ML (10MCG/ML) N 021779 002 Dec 08, 2005 Feb CAHN >A> @ 20MCG/2ML (10MCG/ML) N 021779 001 Dec 29, 2004 Feb CAHN >A> +! 20MCG/ML (20MCG/ML) N 021779 003 Aug 07, 2009 Feb CAHN >D> +! ACTELION PHARMS LTD 10MCG/ML (10MCG/ML) N 021779 002 Dec 08, 2005 Feb CAHN >D> @ 20MCG/2ML (10MCG/ML) N 021779 001 Dec 29, 2004 Feb CAHN >D> +! 20MCG/ML (20MCG/ML) N 021779 003 Aug 07, 2009 Feb CAHN

ISOPROTERENOL HYDROCHLORIDE INJECTABLE;INJECTION ISOPROTERENOL HYDROCHLORIDE >A> AP MICRO LABS 0.2MG/ML A 210845 001 Feb 16, 2021 Feb NEWA

IVERMECTIN TABLET;ORAL STROMECTOL >D> @ MERCK SHARP DOHME 6MG N 050742 001 Nov 22, 1996 Feb CRLD >A> + @ 6MG N 050742 001 Nov 22, 1996 Feb CRLD

LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE >D> +! AUROBINDO PHARMA LTD 300MG;300MG N 022344 001 May 15, 2018 Feb DISC >A> + @ 300MG;300MG N 022344 001 May 15, 2018 Feb DISC

LEVETIRACETAM INJECTABLE;INTRAVENOUS LEVETIRACETAM IN SODIUM CHLORIDE >D> AP AUROBINDO PHARMA LTD 1000MG/100ML (10MG/ML) A 207160 002 Jan 04, 2017 Feb CPOT >A> AP 1GM/100ML (10MG/ML) A 207160 002 Jan 04, 2017 Feb CPOT >D> AP 1500MG/100ML (15MG/ML) A 207160 003 Jan 04, 2017 Feb CPOT >A> AP 1.5GM/100ML (15MG/ML) A 207160 003 Jan 04, 2017 Feb CPOT >D> AP GLAND PHARMA LTD 1000MG/100ML (10MG/ML) A 206880 002 Oct 25, 2017 Feb CPOT >A> AP 1GM/100ML (10MG/ML) A 206880 002 Oct 25, 2017 Feb CPOT >D> AP 1500MG/100ML (15MG/ML) A 206880 003 Oct 25, 2017 Feb CDFR >A> AP 1.5GM/100ML (15MG/ML) A 206880 003 Oct 25, 2017 Feb CDFR >D> AP +! HQ SPECIALITY PHARMA 1000MG/100ML (10MG/ML) N 202543 002 Nov 09, 2011 Feb CPOT >A> AP +! 1GM/100ML (10MG/ML) N 202543 002 Nov 09, 2011 Feb CPOT >D> AP +! 1500MG/100ML (15MG/ML) N 202543 003 Nov 09, 2011 Feb CPOT >A> AP +! 1.5GM/100ML (15MG/ML) N 202543 003 Nov 09, 2011 Feb CPOT >D> AP NEXUS PHARMS 1000MG/100ML (10MG/ML) A 213532 002 Jul 06, 2020 Feb CPOT >A> AP 1GM/100ML (10MG/ML) A 213532 002 Jul 06, 2020 Feb CPOT >D> AP 1500MG/100ML (15MG/ML) A 213532 003 Jul 06, 2020 Feb CPOT >A> AP 1.5GM/100ML (15MG/ML) A 213532 003 Jul 06, 2020 Feb CPOT

Page 15 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

LEVETIRACETAM SOLUTION;ORAL LEVETIRACETAM >A> AA AKORN 100MG/ML A 090601 001 Feb 28, 2012 Feb CAHN >D> AA HI-TECH PHARMACAL 100MG/ML A 090601 001 Feb 28, 2012 Feb CAHN

LEVOTHYROXINE SODIUM POWDER;INTRAVENOUS LEVOTHYROXINE SODIUM >D> AP DR REDDYS 100MCG/VIAL A 208837 001 Mar 27, 2020 Feb DISC >A> @ 100MCG/VIAL A 208837 001 Mar 27, 2020 Feb DISC

LINACLOTIDE CAPSULE;ORAL >D> LINACLOTIDE >D> AB MYLAN 145MCG A 209564 001 Feb 09, 2021 Feb DISC >A> @ 145MCG A 209564 001 Feb 09, 2021 Feb DISC >D> AB 290MCG A 209564 002 Feb 09, 2021 Feb DISC >A> @ 290MCG A 209564 002 Feb 09, 2021 Feb DISC LINZESS >D> AB +! ALLERGAN 145MCG N 202811 001 Aug 30, 2012 Feb CTEC >A> +! 145MCG N 202811 001 Aug 30, 2012 Feb CTEC >D> AB + 290MCG N 202811 002 Aug 30, 2012 Feb CTEC >A> + 290MCG N 202811 002 Aug 30, 2012 Feb CTEC

LINCOMYCIN HYDROCHLORIDE INJECTABLE;INJECTION LINCOCIN >A> AP +! PFIZER EQ 300MG BASE/ML N 050317 001 Dec 29, 1964 Feb CAHN >D> AP +! PHARMACIA AND UPJOHN EQ 300MG BASE/ML N 050317 001 Dec 29, 1964 Feb CAHN

LISINOPRIL TABLET;ORAL LISINOPRIL >A> AB YILING 20MG A 208920 001 Mar 04, 2021 Feb NEWA >A> AB 30MG A 208920 002 Mar 04, 2021 Feb NEWA >A> AB 40MG A 208920 003 Mar 04, 2021 Feb NEWA

LORAZEPAM CONCENTRATE;ORAL LORAZEPAM >A> AA AKORN 2MG/ML A 200169 001 Jan 30, 2012 Feb CAHN >D> AA HI-TECH PHARMA CO 2MG/ML A 200169 001 Jan 30, 2012 Feb CAHN

LOTEPREDNOL ETABONATE SUSPENSION/DROPS;OPHTHALMIC LOTEPREDNOL ETABONATE >A> AB SUN PHARM 0.5% A 212450 001 Feb 26, 2021 Feb NEWA

MACITENTAN TABLET;ORAL OPSUMIT >A> +! ACTELION 10MG N 204410 001 Oct 18, 2013 Feb CAHN >D> +! ACTELION PHARMS LTD 10MG N 204410 001 Oct 18, 2013 Feb CAHN

MAGNESIUM SULFATE INJECTABLE;INJECTION MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER >D> @ BAXTER HLTHCARE CORP 1GM/100ML A 211965 001 Aug 11, 2020 Feb CMFD >A> AP 1GM/100ML A 211965 001 Aug 11, 2020 Feb CMFD MAGNESIUM SULFATE IN PLASTIC CONTAINER >D> @ BAXTER HLTHCARE CORP 2GM/50ML (40MG/ML) A 211966 001 Jun 01, 2020 Feb CMFD >A> AP 2GM/50ML (40MG/ML) A 211966 001 Jun 01, 2020 Feb CMFD >D> @ 4GM/50ML (80MG/ML) A 211966 002 Jun 01, 2020 Feb CMFD >A> AP 4GM/50ML (80MG/ML) A 211966 002 Jun 01, 2020 Feb CMFD >D> @ 4GM/100ML (40MG/ML) A 211966 003 Jun 01, 2020 Feb CMFD >A> AP 4GM/100ML (40MG/ML) A 211966 003 Jun 01, 2020 Feb CMFD

Page 16 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

MELOXICAM CAPSULE;ORAL MELOXICAM >D> LUPIN LTD 5MG A 209487 001 Jun 01, 2020 Feb CTEC >A> AB 5MG A 209487 001 Jun 01, 2020 Feb CTEC >D> ! 10MG A 209487 002 Jun 01, 2020 Feb CTEC >A> AB ! 10MG A 209487 002 Jun 01, 2020 Feb CTEC >A> AB NOVITIUM PHARMA 5MG A 211398 001 Mar 09, 2021 Feb NEWA >A> AB 10MG A 211398 002 Mar 09, 2021 Feb NEWA

>A> FLUFENAMIDE >A> POWDER;INTRAVENOUS >A> PEPAXTO >A> +! ONCOPEPTIDES AB 20MG/VIAL N 214383 001 Feb 26, 2021 Feb NEWA

MEPERIDINE HYDROCHLORIDE INJECTABLE;INJECTION DEMEROL >D> @ US PHARM HOLDINGS 25MG/ML N 005010 007 Apr 18, 1974 Feb CAHN >D> @ 50MG/ML N 005010 002 Apr 14, 1948 Feb CAHN >D> @ 75MG/ML N 005010 009 Apr 18, 1974 Feb CAHN >D> @ 100MG/ML N 005010 003 Apr 18, 1974 Feb CAHN >A> @ VALIDUS PHARMS 25MG/ML N 005010 007 Apr 18, 1974 Feb CAHN >A> @ 50MG/ML N 005010 002 Apr 14, 1948 Feb CAHN >A> @ 75MG/ML N 005010 009 Apr 18, 1974 Feb CAHN >A> @ 100MG/ML N 005010 003 Apr 18, 1974 Feb CAHN SYRUP;ORAL DEMEROL >D> @ US PHARM HOLDINGS 50MG/5ML N 005010 005 Sep 25, 1947 Feb CAHN >A> @ VALIDUS PHARMS 50MG/5ML N 005010 005 Sep 25, 1947 Feb CAHN TABLET;ORAL DEMEROL >D> + @ US PHARM HOLDINGS 50MG N 005010 001 Nov 10, 1942 Feb CAHN >D> + @ 100MG N 005010 004 Sep 25, 1947 Feb CAHN >A> + @ VALIDUS PHARMS 50MG N 005010 001 Nov 10, 1942 Feb CAHN >A> + @ 100MG N 005010 004 Sep 25, 1947 Feb CAHN

MEROPENEM; VABORBACTAM POWDER;INTRAVENOUS VABOMERE >A> +! REMPEX 1GM/VIAL;1GM/VIAL N 209776 001 Aug 29, 2017 Feb CAHN >D> +! REMPEX PHARMS 1GM/VIAL;1GM/VIAL N 209776 001 Aug 29, 2017 Feb CAHN

METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL METFORMIN HYDROCHLORIDE >A> AB3 AJANTA PHARMA LTD 500MG A 213962 001 Mar 09, 2021 Feb NEWA >A> AB3 1GM A 213962 002 Mar 09, 2021 Feb NEWA

METHADONE HYDROCHLORIDE CONCENTRATE;ORAL METHADONE HYDROCHLORIDE >A> AA LANNETT CO INC 10MG/ML A 212094 001 Mar 03, 2021 Feb NEWA

METHENAMINE HIPPURATE TABLET;ORAL HIPREX >D> AB +! US PHARM HOLDINGS 1GM N 017681 001 Sep 09, 1976 Feb CAHN >A> AB +! VALIDUS PHARMS 1GM N 017681 001 Sep 09, 1976 Feb CAHN

METHOCARBAMOL TABLET;ORAL METHOCARBAMOL >D> AA AUROBINDO PHARMA LTD 750MG A 213967 001 Aug 12, 2020 Feb DISC >A> @ 750MG A 213967 001 Aug 12, 2020 Feb DISC

Page 17 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

METHYLPREDNISOLONE TABLET;ORAL METHYLPREDNISOLONE >A> AB PRAXGEN 4MG A 212262 001 Jun 27, 2019 Feb CAHN >D> AB SUNGEN PHARMA 4MG A 212262 001 Jun 27, 2019 Feb CAHN

METOPROLOL SUCCINATE TABLET, EXTENDED RELEASE;ORAL METOPROLOL SUCCINATE >A> AB YICHANG HUMANWELL EQ 100MG TARTRATE A 213854 001 Feb 12, 2021 Feb NEWA >A> AB EQ 200MG TARTRATE A 213854 002 Feb 12, 2021 Feb NEWA

METOPROLOL TARTRATE TABLET;ORAL LOPRESSOR >D> AB + US PHARMS HOLDINGS I 50MG N 017963 001 Aug 07, 1978 Feb CAHN >D> AB + 100MG N 017963 002 Aug 07, 1978 Feb CAHN >A> AB + VALIDUS PHARMS 50MG N 017963 001 Aug 07, 1978 Feb CAHN >A> AB + 100MG N 017963 002 Aug 07, 1978 Feb CAHN

MIGLITOL TABLET;ORAL GLYSET >A> AB +! PFIZER 25MG N 020682 001 Dec 18, 1996 Feb CAHN >A> AB + 50MG N 020682 002 Dec 18, 1996 Feb CAHN >A> AB + 100MG N 020682 003 Dec 18, 1996 Feb CAHN >D> AB +! PHARMACIA AND UPJOHN 25MG N 020682 001 Dec 18, 1996 Feb CAHN >D> AB + 50MG N 020682 002 Dec 18, 1996 Feb CAHN >D> AB + 100MG N 020682 003 Dec 18, 1996 Feb CAHN

MINOXIDIL TABLET;ORAL LONITEN >A> + @ PFIZER 2.5MG N 018154 001 Oct 18, 1979 Feb CAHN >A> + @ 10MG N 018154 003 Oct 18, 1979 Feb CAHN >D> + @ PHARMACIA AND UPJOHN 2.5MG N 018154 001 Oct 18, 1979 Feb CAHN >D> + @ 10MG N 018154 003 Oct 18, 1979 Feb CAHN

MOMETASONE FUROATE SPRAY, METERED;NASAL NASONEX >D> AB +! MERCK SHARP DOHME 0.05MG/SPRAY N 020762 001 Oct 01, 1997 Feb CAHN >A> AB +! ORGANON 0.05MG/SPRAY N 020762 001 Oct 01, 1997 Feb CAHN

MORPHINE SULFATE SOLUTION;ORAL MORPHINE SULFATE >A> AA WINDER LABS LLC 10MG/5ML A 211454 001 Feb 12, 2021 Feb NEWA >A> AA 20MG/5ML A 211454 002 Feb 12, 2021 Feb NEWA >A> AA 100MG/5ML A 211454 003 Feb 12, 2021 Feb NEWA

MYCOPHENOLATE MOFETIL HYDROCHLORIDE INJECTABLE;INJECTION MYCOPHENOLATE MOFETIL HYDROCHLORIDE >A> AP AMNEAL 500MG/VIAL A 211374 001 Mar 05, 2021 Feb NEWA

NAPROXEN SUSPENSION;ORAL NAPROXEN >A> AB NOVITIUM PHARMA 25MG/ML A 211910 001 Mar 10, 2021 Feb NEWA TABLET;ORAL NAPROXEN >D> @ GRANULES 250MG A 074140 001 Dec 21, 1993 Feb CMFD >A> AB 250MG A 074140 001 Dec 21, 1993 Feb CMFD >D> @ 375MG A 074140 002 Dec 21, 1993 Feb CMFD >A> AB 375MG A 074140 002 Dec 21, 1993 Feb CMFD >D> @ 500MG A 074140 003 Dec 21, 1993 Feb CMFD >A> AB 500MG A 074140 003 Dec 21, 1993 Feb CMFD

Page 18 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

NICARDIPINE HYDROCHLORIDE INJECTABLE;INJECTION NICARDIPINE HYDROCHLORIDE >D> AM REGENT 25MG/10ML (2.5MG/ML) A 090534 001 Nov 17, 2009 Feb CHRS >A> ! 25MG/10ML (2.5MG/ML) A 090534 001 Nov 17, 2009 Feb CHRS

NORTRIPTYLINE HYDROCHLORIDE CAPSULE;ORAL HYDROCHLORIDE >A> AB ZYDUS EQ 10MG BASE A 213441 001 Feb 24, 2021 Feb NEWA >A> AB EQ 25MG BASE A 213441 002 Feb 24, 2021 Feb NEWA >A> AB EQ 50MG BASE A 213441 003 Feb 24, 2021 Feb NEWA >A> AB EQ 75MG BASE A 213441 004 Feb 24, 2021 Feb NEWA

OLANZAPINE TABLET, ORALLY DISINTEGRATING;ORAL >A> AB HISUN PHARM HANGZHOU 5MG A 206892 001 Dec 31, 2020 Feb CAHN >A> AB 10MG A 206892 002 Dec 31, 2020 Feb CAHN >A> AB 15MG A 206892 003 Dec 31, 2020 Feb CAHN >A> AB 20MG A 206892 004 Dec 31, 2020 Feb CAHN >D> AB PHARMTAK INC 5MG A 206892 001 Dec 31, 2020 Feb CAHN >D> AB 10MG A 206892 002 Dec 31, 2020 Feb CAHN >D> AB 15MG A 206892 003 Dec 31, 2020 Feb CAHN >D> AB 20MG A 206892 004 Dec 31, 2020 Feb CAHN TABLET;ORAL OLANZAPINE >A> AB HISUN PHARM HANGZHOU 2.5MG A 206924 001 Dec 31, 2020 Feb CAHN >A> AB 5MG A 206924 002 Dec 31, 2020 Feb CAHN >A> AB 7.5MG A 206924 003 Dec 31, 2020 Feb CAHN >A> AB 10MG A 206924 004 Dec 31, 2020 Feb CAHN >A> AB 15MG A 206924 005 Dec 31, 2020 Feb CAHN >A> AB 20MG A 206924 006 Dec 31, 2020 Feb CAHN >D> AB PHARMTAK INC 2.5MG A 206924 001 Dec 31, 2020 Feb CAHN >D> AB 5MG A 206924 002 Dec 31, 2020 Feb CAHN >D> AB 7.5MG A 206924 003 Dec 31, 2020 Feb CAHN >D> AB 10MG A 206924 004 Dec 31, 2020 Feb CAHN >D> AB 15MG A 206924 005 Dec 31, 2020 Feb CAHN >D> AB 20MG A 206924 006 Dec 31, 2020 Feb CAHN

OLOPATADINE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC HYDROCHLORIDE >D> AT ALEMBIC PHARMS LTD EQ 0.1% BASE A 209919 001 Dec 07, 2018 Feb CMKT >D> AT BARR LABS INC EQ 0.2% BASE A 090848 001 Jul 13, 2015 Feb CMKT >D> AT FDC LTD EQ 0.1% BASE A 209282 001 Sep 26, 2019 Feb CMKT >D> AT MYLAN EQ 0.1% BASE A 204392 001 Mar 21, 2018 Feb CMKT

OMEGA-3-ACID ETHYL ESTERS CAPSULE;ORAL LOVAZA >D> AB +! SMITHKLINE BEECHAM 1GM CONTAINS AT LEAST 900MG OF N 021654 001 Nov 10, 2004 Feb CAHN THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS >A> AB +! WOODWARD 1GM CONTAINS AT LEAST 900MG OF N 021654 001 Nov 10, 2004 Feb CAHN THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS

ONDANSETRON FILM;ORAL ZUPLENZ >A> + @ AQUESTIVE 4MG N 022524 001 Jul 02, 2010 Feb CAHN >A> + @ 8MG N 022524 002 Jul 02, 2010 Feb CAHN >D> + @ FORTOVIA 4MG N 022524 001 Jul 02, 2010 Feb CAHN >D> + @ 8MG N 022524 002 Jul 02, 2010 Feb CAHN

Page 19 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

PAROXETINE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL HYDROCHLORIDE >A> AB CSPC OUYI EQ 12.5MG BASE A 213485 001 Feb 16, 2021 Feb NEWA >A> AB EQ 25MG BASE A 213485 002 Feb 16, 2021 Feb NEWA >A> AB EQ 37.5MG BASE A 213485 003 Feb 16, 2021 Feb NEWA

PENTOXIFYLLINE TABLET, EXTENDED RELEASE;ORAL TRENTAL >D> + @ US PHARM HOLDINGS 400MG N 018631 001 Aug 30, 1984 Feb CAHN >A> + @ VALIDUS PHARMS 400MG N 018631 001 Aug 30, 1984 Feb CAHN

PHENYLEPHRINE HYDROCHLORIDE SOLUTION;INTRAVENOUS BIORPHEN >D> +! ETON PHARMS 0.1MG/ML (0.1MG/ML) N 212909 001 Oct 21, 2019 Feb CPOT >A> +! 0.5MG/5ML (0.1MG/ML) N 212909 001 Oct 21, 2019 Feb CPOT

PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE SYRUP;ORAL PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE >A> AA AKORN 5MG/5ML;6.25MG/5ML A 040675 001 Dec 23, 2014 Feb CAHN >D> AA HI TECH 5MG/5ML;6.25MG/5ML A 040675 001 Dec 23, 2014 Feb CAHN

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM INJECTABLE;INJECTION PIPERACILLIN AND TAZOBACTAM >A> AP SAGENT PHARMS INC EQ 2GM BASE/VIAL;EQ 250MG A 208674 001 Feb 16, 2021 Feb NEWA BASE/VIAL >A> AP EQ 3GM BASE/VIAL;EQ 375MG A 208674 002 Feb 16, 2021 Feb NEWA BASE/VIAL >A> AP EQ 4GM BASE/VIAL;EQ 500MG A 208674 003 Feb 16, 2021 Feb NEWA BASE/VIAL >A> AP EQ 36GM BASE/VIAL;EQ 4.5GM A 208675 001 Feb 16, 2021 Feb NEWA BASE/VIAL

POMALIDOMIDE CAPSULE;ORAL POMALIDOMIDE >D> AB BRECKENRIDGE 1MG A 210111 001 Oct 30, 2020 Feb DISC >A> @ 1MG A 210111 001 Oct 30, 2020 Feb DISC >D> AB 2MG A 210111 002 Oct 30, 2020 Feb DISC >A> @ 2MG A 210111 002 Oct 30, 2020 Feb DISC >D> AB 3MG A 210111 003 Oct 30, 2020 Feb DISC >A> @ 3MG A 210111 003 Oct 30, 2020 Feb DISC >D> AB 4MG A 210111 004 Oct 30, 2020 Feb DISC >A> @ 4MG A 210111 004 Oct 30, 2020 Feb DISC

POTASSIUM CHLORIDE CAPSULE, EXTENDED RELEASE;ORAL POTASSIUM CHLORIDE >A> AB GRANULES 8MEQ A 214686 001 Feb 16, 2021 Feb NEWA >A> AB 10MEQ A 214686 002 Feb 16, 2021 Feb NEWA

POTASSIUM CITRATE TABLET, EXTENDED RELEASE;ORAL POTASSIUM CITRATE >D> AB BIONPHARMA INC 10MEQ A 212799 001 Jun 29, 2020 Feb DISC >A> @ 10MEQ A 212799 001 Jun 29, 2020 Feb DISC >D> AB 15MEQ A 212799 002 Jun 29, 2020 Feb DISC >A> @ 15MEQ A 212799 002 Jun 29, 2020 Feb DISC >A> AB EYWA 5MEQ A 214426 001 Feb 19, 2021 Feb NEWA >A> AB 10MEQ A 214426 002 Feb 19, 2021 Feb NEWA >A> AB 15MEQ A 214426 003 Feb 19, 2021 Feb NEWA

Page 20 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

PRAZOSIN HYDROCHLORIDE CAPSULE;ORAL PRAZOSIN HYDROCHLORIDE >D> @ ANI PHARMS INC EQ 1MG BASE A 072577 002 May 16, 1989 Feb CMFD >A> AB EQ 1MG BASE A 072577 002 May 16, 1989 Feb CMFD >D> @ EQ 2MG BASE A 072577 001 May 16, 1989 Feb CMFD >A> AB EQ 2MG BASE A 072577 001 May 16, 1989 Feb CMFD >D> @ EQ 5MG BASE A 072577 003 May 16, 1989 Feb CMFD >A> AB EQ 5MG BASE A 072577 003 May 16, 1989 Feb CMFD

PREDNISONE TABLET;ORAL PREDNISONE >A> AB STRIDES PHARMA 10MG A 208412 001 Feb 11, 2021 Feb NEWA >A> AB 20MG A 208412 002 Feb 11, 2021 Feb NEWA

PREGABALIN CAPSULE;ORAL PREGABALIN >A> AB ALKEM LABS LTD 25MG A 207799 007 Sep 30, 2019 Feb CMS1 >A> AB 50MG A 207799 008 Sep 30, 2019 Feb CMS1

PROMETHAZINE HYDROCHLORIDE SYRUP;ORAL PROMETHAZINE HYDROCHLORIDE >D> AA AMNEAL PHARMS 6.25MG/5ML A 040882 001 Dec 30, 2009 Feb DISC >A> @ 6.25MG/5ML A 040882 001 Dec 30, 2009 Feb DISC

QUETIAPINE FUMARATE TABLET, EXTENDED RELEASE;ORAL FUMARATE >D> AB MYLAN EQ 50MG BASE A 202228 001 Feb 02, 2021 Feb DISC >A> @ EQ 50MG BASE A 202228 001 Feb 02, 2021 Feb DISC >D> AB EQ 150MG BASE A 202228 002 Feb 02, 2021 Feb DISC >A> @ EQ 150MG BASE A 202228 002 Feb 02, 2021 Feb DISC >D> AB EQ 200MG BASE A 202228 003 Feb 02, 2021 Feb DISC >A> @ EQ 200MG BASE A 202228 003 Feb 02, 2021 Feb DISC >D> AB EQ 300MG BASE A 202228 004 Feb 02, 2021 Feb DISC >A> @ EQ 300MG BASE A 202228 004 Feb 02, 2021 Feb DISC >D> AB EQ 400MG BASE A 202228 005 Feb 02, 2021 Feb DISC >A> @ EQ 400MG BASE A 202228 005 Feb 02, 2021 Feb DISC

RANOLAZINE TABLET, EXTENDED RELEASE;ORAL RANOLAZINE >A> AB PRAXGEN 500MG A 212781 001 Mar 23, 2020 Feb CAHN >A> AB 1GM A 212781 002 Mar 23, 2020 Feb CAHN >D> AB SUNGEN PHARMA 500MG A 212781 001 Mar 23, 2020 Feb CAHN >D> AB 1GM A 212781 002 Mar 23, 2020 Feb CAHN

RIFAMPIN INJECTABLE;INJECTION RIFAMPIN >D> AP WATSON PHARMS TEVA 600MG/VIAL A 206736 001 Jan 19, 2016 Feb DISC >A> @ 600MG/VIAL A 206736 001 Jan 19, 2016 Feb DISC

RILUZOLE FILM;ORAL EXSERVAN >D> +! AQUESTIVE THERAP 50MG N 212640 001 Nov 22, 2019 Feb CAHN >A> +! MITSUBISHI HOLDINGS 50MG N 212640 001 Nov 22, 2019 Feb CAHN

RISPERIDONE TABLET, ORALLY DISINTEGRATING;ORAL RISPERDAL >D> AB + JANSSEN PHARMS 0.5MG N 021444 001 Apr 02, 2003 Feb DISC >A> + @ 0.5MG N 021444 001 Apr 02, 2003 Feb DISC >D> AB +! 1MG N 021444 002 Apr 02, 2003 Feb DISC >A> + @ 1MG N 021444 002 Apr 02, 2003 Feb DISC >D> AB + 2MG N 021444 003 Apr 02, 2003 Feb DISC

Page 21 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

RISPERIDONE TABLET, ORALLY DISINTEGRATING;ORAL RISPERDAL >A> + @ 2MG N 021444 003 Apr 02, 2003 Feb DISC >D> AB + 3MG N 021444 004 Dec 23, 2004 Feb DISC >A> + @ 3MG N 021444 004 Dec 23, 2004 Feb DISC >D> AB + 4MG N 021444 005 Dec 23, 2004 Feb DISC >A> + @ 4MG N 021444 005 Dec 23, 2004 Feb DISC RISPERIDONE >D> AB JUBILANT GENERICS 1MG A 090839 002 Nov 04, 2011 Feb CHRS >A> AB ! 1MG A 090839 002 Nov 04, 2011 Feb CHRS

ROSUVASTATIN CALCIUM TABLET;ORAL ROSUVASTATIN CALCIUM >D> @ ZHEJIANG YONGTAI 5MG A 212059 001 Nov 04, 2019 Feb CMFD >A> AB 5MG A 212059 001 Nov 04, 2019 Feb CMFD >D> @ 10MG A 212059 002 Nov 04, 2019 Feb CMFD >A> AB 10MG A 212059 002 Nov 04, 2019 Feb CMFD >D> @ 20MG A 212059 003 Nov 04, 2019 Feb CMFD >A> AB 20MG A 212059 003 Nov 04, 2019 Feb CMFD >D> @ 40MG A 212059 004 Nov 04, 2019 Feb CMFD >A> AB 40MG A 212059 004 Nov 04, 2019 Feb CMFD

RUFINAMIDE SUSPENSION;ORAL RUFINAMIDE >A> AB ALKEM LABS LTD 40MG/ML A 213410 001 Feb 23, 2021 Feb NEWA

SELEXIPAG TABLET;ORAL UPTRAVI >A> + ACTELION 0.2MG N 207947 001 Dec 21, 2015 Feb CAHN >A> +! 0.4MG N 207947 002 Dec 21, 2015 Feb CAHN >A> + 0.6MG N 207947 003 Dec 21, 2015 Feb CAHN >A> + 0.8MG N 207947 004 Dec 21, 2015 Feb CAHN >A> + 1MG N 207947 005 Dec 21, 2015 Feb CAHN >A> + 1.2MG N 207947 006 Dec 21, 2015 Feb CAHN >A> + 1.4MG N 207947 007 Dec 21, 2015 Feb CAHN >A> + 1.6MG N 207947 008 Dec 21, 2015 Feb CAHN >D> + ACTELION PHARMS LTD 0.2MG N 207947 001 Dec 21, 2015 Feb CAHN >D> +! 0.4MG N 207947 002 Dec 21, 2015 Feb CAHN >D> + 0.6MG N 207947 003 Dec 21, 2015 Feb CAHN >D> + 0.8MG N 207947 004 Dec 21, 2015 Feb CAHN >D> + 1MG N 207947 005 Dec 21, 2015 Feb CAHN >D> + 1.2MG N 207947 006 Dec 21, 2015 Feb CAHN >D> + 1.4MG N 207947 007 Dec 21, 2015 Feb CAHN >D> + 1.6MG N 207947 008 Dec 21, 2015 Feb CAHN

SIMVASTATIN TABLET;ORAL ZOCOR >D> AB + MSD MERCK CO 5MG N 019766 001 Dec 23, 1991 Feb CAHN >D> AB + 10MG N 019766 002 Dec 23, 1991 Feb CAHN >D> AB + 20MG N 019766 003 Dec 23, 1991 Feb CAHN >D> AB + 40MG N 019766 004 Dec 23, 1991 Feb CAHN >D> AB +! 80MG N 019766 005 Jul 10, 1998 Feb CAHN >A> AB + ORGANON 5MG N 019766 001 Dec 23, 1991 Feb CAHN >A> AB + 10MG N 019766 002 Dec 23, 1991 Feb CAHN >A> AB + 20MG N 019766 003 Dec 23, 1991 Feb CAHN >A> AB + 40MG N 019766 004 Dec 23, 1991 Feb CAHN >A> AB +! 80MG N 019766 005 Jul 10, 1998 Feb CAHN

SOTALOL HYDROCHLORIDE TABLET;ORAL SOTALOL HYDROCHLORIDE >D> AB MYLAN 80MG A 077616 001 Feb 07, 2007 Feb DISC >A> @ 80MG A 077616 001 Feb 07, 2007 Feb DISC >D> AB 120MG A 077616 002 Feb 07, 2007 Feb DISC >A> @ 120MG A 077616 002 Feb 07, 2007 Feb DISC

Page 22 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

SOTALOL HYDROCHLORIDE TABLET;ORAL SOTALOL HYDROCHLORIDE >D> AB 160MG A 077616 003 Feb 07, 2007 Feb DISC >A> @ 160MG A 077616 003 Feb 07, 2007 Feb DISC

SUCCINYLCHOLINE CHLORIDE INJECTABLE;INJECTION SUCCINYLCHOLINE CHLORIDE >D> AP HIKMA 20MG/ML A 213229 001 Jun 12, 2020 Feb DISC >A> @ 20MG/ML A 213229 001 Jun 12, 2020 Feb DISC

SUMATRIPTAN SPRAY;NASAL SUMATRIPTAN >A> AB CIPLA 20MG/SPRAY A 214209 001 Feb 22, 2021 Feb NEWA >A> AB PHARMASERVE NW 20MG/SPRAY A 208967 001 Feb 17, 2021 Feb NEWA

SUMATRIPTAN SUCCINATE SPRAY;NASAL SUMATRIPTAN >A> AB PERRIGO UK FINCO 5MG/SPRAY A 213465 002 Sep 21, 2020 Feb CMS1

TADALAFIL TABLET;ORAL CIALIS >D> AB + LILLY 2.5MG N 021368 004 Jan 07, 2008 Feb CTEC >A> AB1 + 2.5MG N 021368 004 Jan 07, 2008 Feb CTEC >D> AB + 5MG N 021368 001 Nov 21, 2003 Feb CTEC >A> AB1 + 5MG N 021368 001 Nov 21, 2003 Feb CTEC >D> AB + 10MG N 021368 002 Nov 21, 2003 Feb CTEC >A> AB1 + 10MG N 021368 002 Nov 21, 2003 Feb CTEC TADALAFIL >D> AB ACCORD HLTHCARE 2.5MG A 209167 001 Mar 26, 2019 Feb CTEC >A> AB1 2.5MG A 209167 001 Mar 26, 2019 Feb CTEC >D> AB 5MG A 209167 002 Mar 26, 2019 Feb CTEC >A> AB1 5MG A 209167 002 Mar 26, 2019 Feb CTEC >D> AB 10MG A 209167 003 Oct 23, 2019 Feb CTEC >A> AB1 10MG A 209167 003 Oct 23, 2019 Feb CTEC >D> AB AJANTA PHARMA LTD 2.5MG A 209654 001 Mar 26, 2019 Feb CTEC >A> AB1 2.5MG A 209654 001 Mar 26, 2019 Feb CTEC >D> AB 5MG A 209654 002 Mar 26, 2019 Feb CTEC >A> AB1 5MG A 209654 002 Mar 26, 2019 Feb CTEC >D> AB 10MG A 209654 003 Mar 26, 2019 Feb CTEC >A> AB1 10MG A 209654 003 Mar 26, 2019 Feb CTEC >D> AB ALEMBIC PHARMS LTD 2.5MG A 204809 001 Mar 26, 2019 Feb CTEC >A> AB1 2.5MG A 204809 001 Mar 26, 2019 Feb CTEC >D> AB 5MG A 204809 002 Mar 26, 2019 Feb CTEC >A> AB1 5MG A 204809 002 Mar 26, 2019 Feb CTEC >D> AB 10MG A 204809 003 Mar 26, 2019 Feb CTEC >A> AB1 10MG A 204809 003 Mar 26, 2019 Feb CTEC >D> AB AMNEAL PHARMS CO 2.5MG A 209744 001 Mar 26, 2019 Feb CTEC >A> AB1 2.5MG A 209744 001 Mar 26, 2019 Feb CTEC >D> AB 5MG A 209744 002 Mar 26, 2019 Feb CTEC >A> AB1 5MG A 209744 002 Mar 26, 2019 Feb CTEC >D> AB 10MG A 209744 003 Mar 26, 2019 Feb CTEC >A> AB1 10MG A 209744 003 Mar 26, 2019 Feb CTEC >D> AB AUROBINDO PHARMA LTD 2.5MG A 206285 001 Mar 26, 2019 Feb CTEC >A> AB1 2.5MG A 206285 001 Mar 26, 2019 Feb CTEC >D> AB 5MG A 206285 002 Mar 26, 2019 Feb CTEC >A> AB1 5MG A 206285 002 Mar 26, 2019 Feb CTEC >D> AB 10MG A 206285 003 Mar 26, 2019 Feb CTEC >A> AB1 10MG A 206285 003 Mar 26, 2019 Feb CTEC >D> AB CIPLA 2.5MG A 209539 001 Mar 26, 2019 Feb CTEC >A> AB1 2.5MG A 209539 001 Mar 26, 2019 Feb CTEC >D> AB 5MG A 209539 002 Mar 26, 2019 Feb CTEC >A> AB1 5MG A 209539 002 Mar 26, 2019 Feb CTEC >D> AB 10MG A 209539 003 Mar 26, 2019 Feb CTEC >A> AB1 10MG A 209539 003 Mar 26, 2019 Feb CTEC

Page 23 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

TADALAFIL TABLET;ORAL TADALAFIL >D> AB DR REDDYS LABS LTD 2.5MG A 210069 001 Mar 26, 2019 Feb CTEC >A> AB1 2.5MG A 210069 001 Mar 26, 2019 Feb CTEC >D> AB 5MG A 210069 002 Mar 26, 2019 Feb CTEC >A> AB1 5MG A 210069 002 Mar 26, 2019 Feb CTEC >D> AB 10MG A 210069 003 Mar 26, 2019 Feb CTEC >A> AB1 10MG A 210069 003 Mar 26, 2019 Feb CTEC >D> AB GLENMARK PHARMS LTD 2.5MG A 210716 001 Dec 29, 2020 Feb DISC >A> @ 2.5MG A 210716 001 Dec 29, 2020 Feb DISC >D> AB 5MG A 210716 002 Dec 29, 2020 Feb DISC >A> @ 5MG A 210716 002 Dec 29, 2020 Feb DISC >D> AB 10MG A 210716 003 Dec 29, 2020 Feb DISC >A> @ 10MG A 210716 003 Dec 29, 2020 Feb DISC >D> AB1 20MG A 210716 004 Dec 29, 2020 Feb DISC >A> @ 20MG A 210716 004 Dec 29, 2020 Feb DISC >D> AB HETERO LABS LTD III 2.5MG A 209908 001 Mar 26, 2019 Feb CTEC >A> AB1 2.5MG A 209908 001 Mar 26, 2019 Feb CTEC >D> AB 5MG A 209908 002 Mar 26, 2019 Feb CTEC >A> AB1 5MG A 209908 002 Mar 26, 2019 Feb CTEC >D> AB 10MG A 209908 003 Mar 26, 2019 Feb CTEC >A> AB1 10MG A 209908 003 Mar 26, 2019 Feb CTEC >D> AB LUPIN LTD 2.5MG A 210567 001 Mar 26, 2019 Feb CTEC >A> AB1 2.5MG A 210567 001 Mar 26, 2019 Feb CTEC >D> AB 5MG A 210567 002 Mar 26, 2019 Feb CTEC >A> AB1 5MG A 210567 002 Mar 26, 2019 Feb CTEC >D> AB 10MG A 210567 003 Mar 26, 2019 Feb CTEC >A> AB1 10MG A 210567 003 Mar 26, 2019 Feb CTEC >D> AB MACLEODS PHARMS LTD 2.5MG A 207244 001 Oct 07, 2019 Feb CTEC >A> AB1 2.5MG A 207244 001 Oct 07, 2019 Feb CTEC >D> AB 5MG A 207244 002 Oct 07, 2019 Feb CTEC >A> AB1 5MG A 207244 002 Oct 07, 2019 Feb CTEC >D> AB 10MG A 207244 003 Oct 07, 2019 Feb CTEC >A> AB1 10MG A 207244 003 Oct 07, 2019 Feb CTEC >D> AB MYLAN 2.5MG A 206956 001 Apr 29, 2019 Feb CTEC >A> AB1 2.5MG A 206956 001 Apr 29, 2019 Feb CTEC >D> AB 5MG A 206957 001 Apr 29, 2019 Feb CTEC >A> AB1 5MG A 206957 001 Apr 29, 2019 Feb CTEC >D> AB 10MG A 206956 002 Apr 29, 2019 Feb CTEC >A> AB1 10MG A 206956 002 Apr 29, 2019 Feb CTEC >D> AB QILU 2.5MG A 210420 001 Mar 26, 2019 Feb CTEC >A> AB1 2.5MG A 210420 001 Mar 26, 2019 Feb CTEC >D> AB 5MG A 210420 002 Mar 26, 2019 Feb CTEC >A> AB1 5MG A 210420 002 Mar 26, 2019 Feb CTEC >D> AB 10MG A 210420 003 Mar 26, 2019 Feb CTEC >A> AB1 10MG A 210420 003 Mar 26, 2019 Feb CTEC >D> AB SUN PHARM 2.5MG A 208934 001 Mar 26, 2019 Feb CTEC >A> AB1 2.5MG A 208934 001 Mar 26, 2019 Feb CTEC >D> AB 5MG A 208934 002 Mar 26, 2019 Feb CTEC >A> AB1 5MG A 208934 002 Mar 26, 2019 Feb CTEC >D> AB 10MG A 208934 003 Mar 26, 2019 Feb CTEC >A> AB1 10MG A 208934 003 Mar 26, 2019 Feb CTEC >D> AB SUNSHINE 2.5MG A 211335 001 Mar 26, 2019 Feb CTEC >A> AB1 2.5MG A 211335 001 Mar 26, 2019 Feb CTEC >D> AB 5MG A 211335 002 Mar 26, 2019 Feb CTEC >A> AB1 5MG A 211335 002 Mar 26, 2019 Feb CTEC >D> AB 10MG A 211335 003 Mar 26, 2019 Feb CTEC >A> AB1 10MG A 211335 003 Mar 26, 2019 Feb CTEC >D> AB TEVA PHARMS USA 2.5MG A 090141 001 May 22, 2018 Feb CTEC >A> AB1 2.5MG A 090141 001 May 22, 2018 Feb CTEC >D> AB 5MG A 090141 002 May 22, 2018 Feb CTEC >A> AB1 5MG A 090141 002 May 22, 2018 Feb CTEC >D> AB 10MG A 090141 003 May 22, 2018 Feb CTEC >A> AB1 10MG A 090141 003 May 22, 2018 Feb CTEC >D> AB TORRENT 2.5MG A 211839 001 Mar 26, 2019 Feb CTEC >A> AB1 2.5MG A 211839 001 Mar 26, 2019 Feb CTEC >D> AB 5MG A 211839 002 Mar 26, 2019 Feb CTEC

Page 24 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

TADALAFIL TABLET;ORAL TADALAFIL >A> AB1 5MG A 211839 002 Mar 26, 2019 Feb CTEC >D> AB 10MG A 211839 003 Mar 26, 2019 Feb CTEC >A> AB1 10MG A 211839 003 Mar 26, 2019 Feb CTEC >D> AB UMEDICA LABS PVT LTD 2.5MG A 211298 001 Oct 23, 2020 Feb CTEC >A> AB1 2.5MG A 211298 001 Oct 23, 2020 Feb CTEC >D> AB 5MG A 211298 002 Oct 23, 2020 Feb CTEC >A> AB1 5MG A 211298 002 Oct 23, 2020 Feb CTEC >D> AB 10MG A 211298 003 Oct 23, 2020 Feb CTEC >A> AB1 10MG A 211298 003 Oct 23, 2020 Feb CTEC >D> AB UNICHEM 2.5MG A 209250 001 Mar 26, 2019 Feb CTEC >A> AB1 2.5MG A 209250 001 Mar 26, 2019 Feb CTEC >D> AB 5MG A 209250 002 Mar 26, 2019 Feb CTEC >A> AB1 5MG A 209250 002 Mar 26, 2019 Feb CTEC >D> AB 10MG A 209250 003 Mar 26, 2019 Feb CTEC >A> AB1 10MG A 209250 003 Mar 26, 2019 Feb CTEC >D> AB YANGLING BUCHANG 2.5MG A 208824 001 Oct 27, 2020 Feb CTEC >A> AB1 2.5MG A 208824 001 Oct 27, 2020 Feb CTEC >D> AB 5MG A 208824 002 Oct 27, 2020 Feb CTEC >A> AB1 5MG A 208824 002 Oct 27, 2020 Feb CTEC >D> AB 10MG A 208824 003 Oct 27, 2020 Feb CTEC >A> AB1 10MG A 208824 003 Oct 27, 2020 Feb CTEC >D> AB ZYDUS PHARMS 2.5MG A 206693 001 Mar 26, 2019 Feb CTEC >A> AB1 2.5MG A 206693 001 Mar 26, 2019 Feb CTEC >D> AB 5MG A 206693 002 Mar 26, 2019 Feb CTEC >A> AB1 5MG A 206693 002 Mar 26, 2019 Feb CTEC >D> AB 10MG A 206693 003 Mar 26, 2019 Feb CTEC >A> AB1 10MG A 206693 003 Mar 26, 2019 Feb CTEC

TAVABOROLE SOLUTION;TOPICAL TAVABOROLE >D> AB FLATWING 5.0% A 211963 001 Feb 03, 2021 Feb CAHN >A> AB IDENTIRX 5% A 211963 001 Feb 03, 2021 Feb CAHN

TELMISARTAN TABLET;ORAL TELMISARTAN >D> @ CELLTRION 20MG A 078710 001 Jan 08, 2014 Feb CMFD >A> AB 20MG A 078710 001 Jan 08, 2014 Feb CMFD >D> @ 40MG A 078710 002 Jan 08, 2014 Feb CMFD >A> AB 40MG A 078710 002 Jan 08, 2014 Feb CMFD >D> @ 80MG A 078710 003 Jan 08, 2014 Feb CMFD >A> AB 80MG A 078710 003 Jan 08, 2014 Feb CMFD

TEMOZOLOMIDE CAPSULE;ORAL >D> @ BARR 5MG A 078879 001 Mar 01, 2010 Feb CAHN >D> @ 20MG A 078879 002 Mar 01, 2010 Feb CAHN >D> @ 100MG A 078879 003 Mar 01, 2010 Feb CAHN >D> @ 140MG A 078879 005 Mar 01, 2010 Feb CAHN >D> @ 180MG A 078879 006 Mar 01, 2010 Feb CAHN >D> @ 250MG A 078879 004 Mar 01, 2010 Feb CAHN >A> @ HERITAGE 5MG A 078879 001 Mar 01, 2010 Feb CAHN >A> @ 20MG A 078879 002 Mar 01, 2010 Feb CAHN >A> @ 100MG A 078879 003 Mar 01, 2010 Feb CAHN >A> @ 140MG A 078879 005 Mar 01, 2010 Feb CAHN >A> @ 180MG A 078879 006 Mar 01, 2010 Feb CAHN >A> @ 250MG A 078879 004 Mar 01, 2010 Feb CAHN

>A> TEPOTINIB HYDROCHLORIDE >A> TABLET;ORAL >A> TEPMETKO >A> +! EMD SERONO INC EQ 225MG BASE N 214096 001 Feb 03, 2021 Feb NEWA

Page 25 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

TERIFLUNOMIDE TABLET;ORAL TERIFLUNOMIDE >D> AB IMPAX 14MG A 209677 001 Jun 17, 2020 Feb DISC >A> @ 14MG A 209677 001 Jun 17, 2020 Feb DISC

TESTOSTERONE GEL, METERED;TRANSDERMAL TESTOSTERONE >A> AB ALEOR DERMACEUTICALS 1.62% (20.25MG/1.25GM A 213922 001 Mar 03, 2021 Feb NEWA ACTUATION) GEL;TRANSDERMAL TESTOSTERONE >A> AB2 ACTAVIS LABS UT INC 1.62% (20.25MG/1.25GM PACKET) A 204570 002 Jul 17, 2020 Feb NEWA >A> AB2 1.62% (40.5MG/2.5GM PACKET) A 204570 003 Jul 17, 2020 Feb NEWA

THIOTEPA POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL >A> AP GLAND PHARMA LTD 15MG/VIAL A 214222 001 Mar 08, 2021 Feb NEWA

TIZANIDINE HYDROCHLORIDE TABLET;ORAL TIZANIDINE HYDROCHLORIDE >A> AB CADILA EQ 2MG BASE A 208187 001 Mar 09, 2018 Feb CAHN >A> AB EQ 4MG BASE A 208187 002 Mar 09, 2018 Feb CAHN >D> AB MYLAN EQ 4MG BASE A 076354 002 Mar 28, 2003 Feb DISC >A> @ EQ 4MG BASE A 076354 002 Mar 28, 2003 Feb DISC >D> AB ZYDUS PHARMS EQ 2MG BASE A 208187 001 Mar 09, 2018 Feb CAHN >D> AB EQ 4MG BASE A 208187 002 Mar 09, 2018 Feb CAHN

TOBRAMYCIN SOLUTION/DROPS;OPHTHALMIC TOBRAMYCIN >A> AT GLAND PHARMA LTD 0.3% A 212628 001 Mar 09, 2021 Feb NEWA

TOBRAMYCIN SULFATE INJECTABLE;INJECTION TOBRAMYCIN SULFATE >A> AP GLAND PHARMA LTD EQ 10MG BASE/ML A 209621 001 Feb 11, 2021 Feb NEWA >A> AP EQ 40MG BASE/ML A 209621 002 Feb 11, 2021 Feb NEWA

TOFACITINIB CITRATE SOLUTION;ORAL XELJANZ >A> +! PFIZER EQ 1MG/ML BASE N 213082 001 Sep 25, 2020 Feb CMS1 Xeljanz >D> +! PFIZER EQ 1MG/ML BASE N 213082 001 Sep 25, 2020 Feb CMS1

TOLVAPTAN TABLET;ORAL SAMSCA >A> + OTSUKA 15MG N 022275 001 May 19, 2009 Feb CAHN >A> AB +! 30MG N 022275 002 May 19, 2009 Feb CAHN >A> + @ 60MG N 022275 003 May 19, 2009 Feb CAHN >D> + OTSUKA AMERICA PHARM 15MG N 022275 001 May 19, 2009 Feb CAHN >D> AB +! 30MG N 022275 002 May 19, 2009 Feb CAHN >D> + @ 60MG N 022275 003 May 19, 2009 Feb CAHN

TRAMADOL HYDROCHLORIDE TABLET;ORAL HYDROCHLORIDE >D> @ POLYGEN PHARMS 50MG A 206706 001 Jul 02, 2019 Feb CMFD >A> AB 50MG A 206706 001 Jul 02, 2019 Feb CMFD

TRAZODONE HYDROCHLORIDE TABLET;ORAL TRAZODONE HYDROCHLORIDE >D> @ AUROLIFE PHARMA LLC 50MG A 204852 001 Feb 05, 2020 Feb CMFD >A> AB 50MG A 204852 001 Feb 05, 2020 Feb CMFD >D> @ 100MG A 204852 002 Feb 05, 2020 Feb CMFD

Page 26 of 28 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

TRAZODONE HYDROCHLORIDE TABLET;ORAL TRAZODONE HYDROCHLORIDE >A> AB 100MG A 204852 002 Feb 05, 2020 Feb CMFD >D> @ 150MG A 204852 003 Feb 05, 2020 Feb CMFD >A> AB 150MG A 204852 003 Feb 05, 2020 Feb CMFD >D> @ 300MG A 204852 004 Feb 05, 2020 Feb CMFD >A> AB 300MG A 204852 004 Feb 05, 2020 Feb CMFD

TREPROSTINIL INJECTABLE;IV (INFUSION), SUBCUTANEOUS TREPROSTINIL >A> AP ALEMBIC GLOBAL 1MG/ML A 211574 001 Feb 11, 2021 Feb NEWA >A> AP 2.5MG/ML A 211574 002 Feb 11, 2021 Feb NEWA >A> AP 5MG/ML A 211574 003 Feb 11, 2021 Feb NEWA >A> AP 10MG/ML A 211574 004 Feb 11, 2021 Feb NEWA

TRIAZOLAM TABLET;ORAL HALCION >A> AB + PFIZER 0.125MG N 017892 003 Apr 26, 1985 Feb CAHN >A> AB +! 0.25MG N 017892 001 Nov 15, 1982 Feb CAHN >A> @ 0.5MG N 017892 002 Nov 15, 1982 Feb CAHN >D> AB + PHARMACIA AND UPJOHN 0.125MG N 017892 003 Apr 26, 1985 Feb CAHN >D> AB +! 0.25MG N 017892 001 Nov 15, 1982 Feb CAHN >D> @ 0.5MG N 017892 002 Nov 15, 1982 Feb CAHN

>A> TRILACICLIB DIHYDROCHLORIDE >A> POWDER;INTRAVENOUS >A> COSELA >A> +! G1 THERAP EQ 300MG BASE/VIAL N 214200 001 Feb 12, 2021 Feb NEWA

>A> UMBRALISIB TOSYLATE >A> TABLET;ORAL >A> UKONIQ >A> +! TG THERAPS EQ 200MG BASE N 213176 001 Feb 05, 2021 Feb NEWA

VALGANCICLOVIR HYDROCHLORIDE TABLET;ORAL VALGANCICLOVIR HYDROCHLORIDE >A> AB MYLAN EQ 450MG BASE A 205151 001 Mar 03, 2021 Feb NEWA

VANCOMYCIN HYDROCHLORIDE INJECTABLE;INJECTION VANCOMYCIN HYDROCHLORIDE >D> AP HIKMA EQ 500MG BASE/VIAL A 203300 001 Aug 11, 2020 Feb DISC >A> @ EQ 500MG BASE/VIAL A 203300 001 Aug 11, 2020 Feb DISC >D> AP EQ 1GM BASE/VIAL A 203300 002 Aug 11, 2020 Feb DISC >A> @ EQ 1GM BASE/VIAL A 203300 002 Aug 11, 2020 Feb DISC

VORICONAZOLE INJECTABLE;INTRAVENOUS VORICONAZOLE >A> AP ALMAJECT 200MG/VIAL A 206398 001 Mar 23, 2016 Feb CAHN >D> AP ALVOGEN 200MG/VIAL A 206398 001 Mar 23, 2016 Feb CAHN

Page 27 of 28 ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST

ACETAMINOPHEN; ASPIRIN; CAFFEINE TABLET;ORAL ACETAMINOPHEN, ASPIRIN AND CAFFEINE >A> GRANULES 250MG;250MG;65MG A 214039 001 Feb 23, 2021 Feb NEWA

IBUPROFEN SUSPENSION;ORAL IBUPROFEN >A> STRIDES PHARMA 100MG/5ML A 211666 001 Feb 22, 2021 Feb NEWA

KETOCONAZOLE SHAMPOO;TOPICAL >D> NIZORAL A-D >D> +! KRAMER 1% N 020310 001 Oct 10, 1997 Feb CTNA >A> NIZORAL ANTI-DANDRUFF >A> +! KRAMER 1% N 020310 001 Oct 10, 1997 Feb CTNA

OLOPATADINE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC OLOPATADINE HYDROCHLORIDE >A> ALEMBIC PHARMS LTD EQ 0.1% BASE A 209919 001 Dec 07, 2018 Feb CMKT >A> BARR LABS INC EQ 0.2% BASE A 090848 001 Jul 13, 2015 Feb CMKT >A> FDC LTD EQ 0.1% BASE A 209282 001 Sep 26, 2019 Feb CMKT >A> MYLAN EQ 0.1% BASE A 204392 001 Mar 21, 2018 Feb CMKT

CURRENT MONTH ADDS/DELETES LIST NOTE:

The List is sorted by Ingredient(s) and, within each grouping, by the Dosage Form; Route and then by trade name.

The individual product record contains the Therapeutic Equivalence Code, Reference Listed Drug symbol, Reference Standard Drug symbol, applicant holder, strength(s), New Drug Application number, product number, and approval date. The last two columns describe the action. The Action Month is the CS month the action occurred. The OB Action is the type of change that has occurred.

New ingredient(s), new dosage form; route(s), new trade names, and new product additions are preceded by >A> during the action month. The change month is the current CS month; the change code for new approvals is NEWA.

Changes to currently listed products will list two records. The deleted product record will be proceeded by >D>. The product record change addition being made will be preceded by >A>.

The change code description:

NEWA New drug product approval usually in the supplement month. NFTG New first time generic approval. CAHN** Applicant holder firm name has changed. CAIN Change. There has been a change in the Ingredient(s) name. All products will be deleted under the old name and all products will be added under the changed ingredient(s) name. CDFR Change. Dosage Form; Route of Administration. CFTG Change. A first time generic for the innovator product. A TE Code is added. CMFD Change. The product is moved from the Discontinued Section due to a change in marketing status. CMKT Change. RX to OTC marketing status switch. CMS1 Change. Miscellaneous addition to list. CMS2 Change. Miscellaneous deletion from list. CPOT Change. Potency amount/unit. CRLD Change. Reference Listed Drug. CHRS Change. Reference Standard. CTEC Change. Therapeutic Equivalence Code. CTNA Change. Trade Name. DISC Discontinued. The Rx or OTC listed product is not being marketed and will be moved to the discontinued section in the next edition.

**Note: The Cumulative Supplement (CS) currently displays a condensed 20 character collapsed applicant holder firm name and the Electronic Orange Book(EOB)query may display up to a 240 character full applicant holder firm name. An applicant holder firm name change usually changes both the collapsed name and long name. On occasion, only the long name is changed resulting in the CS displaying only the collapsed name for the >D> and >A> action. The new firm long name will display in the EOB query.

Page 28 of 28